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Abstract 
The generation of antigen receptors requires a gene rearrangement process 
known as V(D)J recombination. Double stranded breaks produced during recombination 
must be repaired by the nonhomologous end joining pathway. One critical factor 
important for this recombination event is the Artemis nuclease, which processes the 
DNA ends before ligation. Patients with mutations affecting the catalytic N-terminal 
domain of Artemis are radiosensitive and do not produce B and T cells. Hypomorphic 
Artemis mutations involving the nonconserved C-terminus have also been described. 
These patients have a partial B and T cell deficiency but exhibit a predisposition to 
lymphoid malignancies. 
Here, I study the regulation of the Artemis nuclease during V(D)J recombination 
and the genetic interactions between the Artemis C-terminal domain and DNA damage 
inducible protein kinase, ATM. I define a region in the C-terminus that is required for 
endonucleolytic activity and preventing aberrant V(D)J recombination. The findings 
presented here also suggest that there may be previously undescribed regulatory 
features located in the Artemis N-terminus that are separate from catalytic activity. To 
analyze the in vivo consequences resulting from the loss of the Artemis C-terminus, I 
utilized a hypomorphic Artemis mouse model harboring an allele that results in C-
terminal truncation, Artemis-P70. Cellular and in vivo assays suggest that the Artemis 
C-terminus and the ATM kinase cooperate to facilitate V(D)J recombination and loss of 
both factors can result in a lymphocyte deficiency that is more severe than in mice 
deficient for one factor. Although ATM deficient mice succumb to thymic lymphoma, 
mice harboring homozygous mutations in both Artemis-P70 and ATM are surprisingly 
tumor-free. These mice, however, had inflamed colons with T cell and neutrophil 
infiltration.  
These findings together emphasize the importance of the regulatory domains of 
Artemis. A disregulated nuclease can facilitate aberrant recombination and that can 
disrupt proper lymphocyte development. A lymphocyte defect may operate in concert 
xi 
 
with other factors such as DNA repair deficiency and cytokine imbalance which together 
could promote chronic inflammation. Finally, results presented here suggest that there 
may be other means of Artemis regulation that are dependent on features located in the 
conserved N-terminal domain. 
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Chapter 1 
Introduction 
 
Introduction to V(D)J recombination 
The adaptive immune system, present in all jawed vertebrates, can recognize a 
myriad of invading pathogens [1]. This recognition depends on the B and T 
lymphocytes, cells which express antigen receptors capable of recognizing antigens 
from the external environment. When antigen receptor proteins were first sequenced, it 
was found that these proteins contained regions that were common to other antigen 
receptor proteins but they also contained other regions of high variability. The antigen 
receptor protein seemed to originate from one gene in some regions and thousands of 
genes in other regions. For many years, it was unclear how a protein of this type could 
be created by the cell (Figure 1.1).  
Eventually, it became known that antigen receptors were encoded by a novel 
process in which gene segments were rearranged to produce the variable regions of the 
receptors [2]. These gene segments that make up the variable regions are grouped into 
three categories: variable (V), diversity (D), and joining (J) and accordingly, the process 
is referred to as V(D)J recombination (Figure 1.2). The rearrangement of these 
segments is highly regulated and ordered so that only specific types of gene segments 
are joined and only during specific stages of lymphocyte development. 
The development of a T-cell requires that it rearranges its antigen receptor, the 
T-cell receptor (TCR). TCRs can be generally classified into two categories based on 
the type of receptor on their surface: those with receptors comprised of an -chain and 
a -chain ( T cells) and those with receptors that are comprised of a -chain and a -
chain ( T cells). B cells on the other hand have B cell receptors (BCRs or 
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immunoglobulins) which are comprised of two heavy chains (IgH) and two light chains 
(IgL).  
V(D)J rearrangements to generate the TCRs and BCRs begin with the 
introduction of DNA double stranded breaks (DSBs) by the Rag endonuclease. The Rag 
endonuclease consists of two lymphocyte-specific proteins, recombination activating 
gene 1 and 2 (RAG1 and RAG2) [3]. Rag creates a double stranded break at a 
recognition site referred to as the recombination signal sequence (RSS), a nucleotide 
sequence adjacent to the gene segments. The RSS contains a conserved 7 nucleotide 
(heptamer) and 9 nucleotide (nonamer) sequence and a poorly conserved spacer 
sequence of either 12 or 23 nucleotides. For this reason, the recognition sites are 
categorized as either 12RSS or 23RSS depending on the nonconserved spacer 
sequence. The RAG proteins show a preference for the recombination between 
12RSSs and 23RSSs [4, 5]. This preference of the RAG machinery adds a level of 
regulation to ensure the cleavage and joining of the proper gene segments in the 
correct orientation.   
The Rag endonuclease is thought to assemble on a single RSS and this is then 
followed by the capture of the RSS partner. Some studies have suggested that Rag has 
a preference for binding and creating a single-stranded nick the 12RSS first and then 
capturing the 23RSS [6, 7]. However, another study using chromatin 
immunoprecipitation  in lymphocytes found no increased preference for Rag binding to 
12RSS over 23RSS [8]. This difference in findings may indicate that while the Rag 
endonuclease may bind to either 12RSS and 23RSS first, the nicking of DNA may be 
occurring at a faster rate at 12RSS [9]. (Figure 1.3) 
RAG1 and RAG2 are sufficient to bind RSSs and promote cleavage. However, in 
vivo, this process likely occurs with two other proteins important for DNA bending: high 
mobility group box 1 (HMGB1) and high mobility group box 2 (HMGB2). The presence 
of these two proteins support Rag binding at 23RSS and cleavage of synapsed RSSs 
[10].  While the nicking of DNA can occur after Rag binding, the cleavage and 
generation of hairpin ends requires the synapsis of two paired RSSs [11]. The single-
stranded DNA nick creates a 3’ hydroxyl group which can act as a nucleophile. The Rag 
endonuclease uses the hydroxyl group to catalyze a nucleophilic attack of the second 
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strand cleaving the DNA to produce two types of ends: a covalently sealed hairpin 
coding end (CE) adjacent to the gene segment and a 5’ phosphorylated blunt signal end 
(SE) that contains the recombination signal sequence. In order to generate the 
rearranged receptor gene, the hairpin coding ends must be opened and joined to create 
coding joins (CJs). The signal ends are also joined to created signal joins (SJs) but 
because they are blunt, they do not require processing. [12] 
DNA ends that have been created by the Rag endonuclease are thought to be 
held in close proximity to facilitate subsequent ligation steps. The Rag endonuclease 
itself is thought to play an important role in the synapsis of DNA ends. After DNA 
cleavage, it has been shown that all four DNA ends, two signal and two coding ends, 
are retained in a protein-DNA complex referred to as the post-cleavage complex (PCC) 
[13, 14]. Another factor important to DNA end synapsis is the nonhomologous end 
joining protein (NHEJ) DNA-protein kinase catalytic subunit (DNA-PKcs) [15, 16]. Using 
electron microscopy, it was shown that DNA-PKcs along with the DNA-end sensor 
proteins KU70 and KU80 (in complex, referred to as DNA-PK) can bind to the DNA 
ends of a linearized plasmid and promote a circularized DNA formation.  
While these factors may be important for promoting the retention of Rag 
generated ends, other factors may be important for bringing together gene segments 
that may be separated by several megabases. Using two-color fluorescence in-situ 
hybridization, one group found that the IgH locus was compacted during the pro-B cell 
stage, the stage in which B cells rearrange this locus [17]. The compaction of the IgH 
locus also was not apparent in developing T cells suggesting that this was lineage 
specific. Using a similar approach, TCR loci compaction has also been observed in 
developing T cells during rearrangement stages but not in developing B cells [18]. This 
compaction was not found to be dependent on the Rag endonuclease [17] but instead 
on the transcription factors Pax5, CCTF, and the protein complex cohesin [19].   
Taccioli et al. determined that the Rag generated ends are joined by the NHEJ 
pathway [20]. This group used several Chinese hamster ovary (CHO) cell lines deficient 
in various DNA repair pathways including nucleotide excision repair, single stranded 
break repair, and double stranded break repair and tested the ability of these cells to 
recombine a plasmid substrate. They found that cell lines deficient in DSB repair were 
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unable to efficiently join Rag generated breaks. Those DSB-deficient CHO cell lines 
were later discovered to be deficient in KU80 [21], XRCC4 [22], and DNA-PKcs [23], all 
proteins that participate in the NHEJ pathway. Interestingly, DNA-PKcs deficient cell 
lines exhibited impaired coding joining but not signal joining illustrating the differences in 
the way the two types of DNA ends are handled. This uncoupling of the two joining 
events was later found to be a product of the requirement for DNA-PKcs-assisted 
coding end processing. 
 In addition to cleaving the DNA, the Rag endonuclease is thought to be 
important for shepherding DNA ends specifically to nonhomologous end joining. Cui and 
Meek found that DSB-breaks on a plasmid substrate induced by the endonuclease I-
Sce1 were repaired efficiently in NHEJ-deficient CHO cell lines [24]. However, when the 
cleavage of I-Sce1 sites were coupled to the Rag complex by fusing the RAG2 protein 
with the I-Sce1 endonuclease, efficient repair of the breaks became dependent on 
NHEJ factors. 
Nonhomologous end joining 
There are seven key NHEJ factors: KU70, KU80, DNA-PKcs, XRCC4, XLF, 
LIG4, and Artemis (Figure 1.4). KU70 and KU80 both together form the Ku heterodimer. 
Ku is the first factor to recognize and bind the double stranded break. DNA-PKcs is then 
recruited to the breaks and together, DNA-PKcs and KU70/80 form the DNA-PK protein 
complex. DNA-PKcs is a serine/threonine protein kinase and a member of the 
phosphatidylinositol 3-kinase-related kinase (PIKK) family which includes the DNA 
repair kinases ATM and ataxia-telangiectasia and Rad3 related protein (ATR). DNA-
PKcs has been shown to phosphorylate the other NHEJ factors but it has not been 
established that any of these phosphorylation events are functionally important. 
However, it has been shown that DNA-PKcs autophosphorylation is important for the 
activity of the Artemis nuclease [25]. Artemis activity is important for the repair of a 
subset of DNA breaks and has an essential role during V(D)J recombination opening of 
hairpin coding ends. Because this project focused on the Artemis nuclease, a more 
detailed review of this protein will follow in the next section.  
The final stage of repair involves the ligation of the DNA ends. LIG4 and XRCC4 
as a complex perform this last step. Interaction between LIG4 and XRCC4 is required 
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for LIG4 stability [26]. The most recently discovered NHEJ factor XLF/Cernunnos also 
participates in this step facilitating the ligation of DNA breaks and during V(D)J 
recombination [27, 28]. XRCC4 and XLF have also been shown to form filaments and 
the interaction between the two proteins may aid in bridging DNA ends during coding 
joining [29, 30]. 
The joining of coding ends during V(D)J recombination often results in an 
imprecise joint, that is, nucleotides can be added or deleted from the ends prior to 
ligation. There are two types of nucleotide additions: P-nucleotides and N-nucleotides. 
Palindromic additions, or P-nucleotides, arise as a product of Artemis hairpin opening. 
Artemis will sometimes cleave the DNA at a site proximal to the hairpin apex creating a 
single-stranded overhang with an inverted repeat. The single-stranded DNA overhang is 
then used as a template and this region is filled in by either polymerase μ (Pol μ) or 
polymerase λ (Pol λ) prior to ligation. Nucleotide additions can also be non-templated. 
N-nucleotides are the product of the lymphoid-specific polymerase terminal 
deoxynucleotidyl-transferase (TdT) which can add random nucleotides to coding ends 
prior to ligation [31]. Coding joints can also have nucleotides deleted although it is 
unclear what exonuclease is responsible for this end ‘nibbling’ [32]. The nucleotide 
additions and deletions add another layer of diversity to the antigen receptor repertoire. 
However, this process can also result in out-of-frame, non-productive rearrangements 
which will be discussed later in this chapter.  
The Artemis nuclease 
ARTEMIS was first discovered in radiosensitive severe combined 
immunodeficiency (RS-SCID) patients of Athabascan American Indian origin [33]. 
These patients had an absence of B and T cells and patient fibroblasts were sensitive to 
radiation. The de Villartay group found that these patients had mutations in a previously 
undescribed gene. They named this new gene after the Greek goddess Artemis, a 
protector of children, presumably because RS-SCID patients generally die within the 
first year of life. As the patient phenotypes would predict, fibroblasts from these patients 
were unable to join two coding ends from a plasmid substrate and had been previously 
shown to be sensitive to ionizing radiation [34]. They analyzed the sequence of the 
ARTEMIS gene and found that it comprised of a metallo-β-lactamase domain and 
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another domain that was conserved among members of the SNM1/PSO2 family of 
proteins. Moshous et al. named this second conserved domain β-CASP (metallo-β-
lactamase associated CPSF Artemis SNM1/PSO2 domain). At the time of this first 
report, it was not known what factor was responsible for the cleavage of hairpin coding 
ends during V(D)J recombination. Because of what was known about other proteins that 
shared conserved domains with Artemis, the authors speculated that Artemis could 
have enzymatic activity and furthermore, that they may have identified the nuclease 
responsible for opening Rag generated hairpin ends.  
Additional support for the role of Artemis in opening V(D)J hairpin ends came in 
biochemical experiments performed by the Lieber group [35]. Ma et al. found that 
Artemis did indeed have enzymatic activity. Artemis was able to cleave a 5’ and 3’ 
overhang DNA substrate as well as a hairpin substrate. However, this enzymatic activity 
of Artemis was dependent on its interaction with DNA-PKcs. They found that while 
Artemis is phosphorylated by DNA-PKcs, phosphorylation of Artemis alone was not 
sufficient for activity. Rather, DNA-PKcs had to be present in order for Artemis to be 
active. This group also showed that Artemis was able to cleave Rag-generated hairpin 
end in a biochemical assay. Together, these data provided strong evidence that Artemis 
was indeed the hairpin opening factor during V(D)J recombination.  
The generation of an Artemis-deficient mouse by the Alt group provided in vivo 
evidence of the role of Artemis in V(D)J recombination [36]. Like the human patients, 
Artemis-deficient mouse embryonic fibroblasts were sensitive to ionizing radiation and 
were unable to support coding joining of a plasmid substrate but loss of Artemis did not 
affect signal joining. As it would be predicted for a V(D)J recombination deficient mouse, 
these mice also had a B and T cell deficiency. This group showed using ligation-
mediated PCR that Artemis-deficient thymocytes accumulated closed coding ends 
providing in vivo evidence that the Artemis nuclease is responsible for opening hairpin 
coding ends. 
The regulation of the Artemis nuclease 
 The mammalian SNM1 family of DNA nucleases includes two other members, 
SNM1A and SNM1B/Apollo. These three nucleases share the conserved metallo-β-
lactamase domain and the β-CASP domain (MβL/βCASP) (Figure 1.5) [37]. The 
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Artemis protein has in its N-terminus the MβL/βCASP domain and in its C-terminus, a 
poorly characterized domain unique to Artemis. In this study, we will define the N-
terminal domain as the amino acids between 1 and 385 and the C-terminal domain as 
the amino acids between 385 and 692. The entirety of the C-terminal domain is coded 
by exon 14. Several studies have found that the N-terminal domain of Artemis is able to 
functionally complement V(D)J recombination of artificial plasmid substrates indicating 
that the N-terminus is the catalytic domain [38, 39]. 
In an attempt to study how Artemis is regulated, many studies have focused on 
two aspects of the protein: phosphorylation and its interaction with the kinase DNA-
PKcs (Figure 1.8). The Artemis protein was shown to interact with DNA-PKcs in 
biochemical assays and furthermore, incubating the two proteins together resulted in 
the phosphorylation of Artemis [35, 40, 41]. This suggested that DNA-PKcs could 
possibly regulate Artemis through its kinase activity. Poinsignon et al. found that Artemis 
could be phosphorylated in DNA-PKcs-deficient CHO cell lines suggesting that other 
kinases may also act on Artemis [42]. This study and others have suggested that the 
kinase ATM can phosphorylate Artemis and that it seemed to be the predominant 
kinase during recovery from ionizing radiation [42, 43]. However, DNA-PKcs can also 
phosphorylate Artemis in response to DNA damage [41] and the overlap between the 
two kinases may make the dissection of their respective roles difficult.  
In order to further characterize this possible regulatory event, several groups 
identified the phosphorylation sites of Artemis and attempted to determine its functional 
importance. ATM and DNA-PKcs has been reported to phosphorylate its substrates at 
serines or threonines followed by a glutamine (SQ/TQ). The Artemis protein has 10 
SQ/TQ sites, 8 of them in the C-terminal domain (Figure 1.8). Using C-terminal 
truncations mutants, it was found that most of the phosphorylation occurs at the C-
terminus [41, 44]. Other groups have mutated the SQ sites in the C-terminus which 
prevented phosphorylation showing that these sites are indeed the actual 
phosphorylation sites [25, 42]. 
Although there has been much research on the phosphorylation of Artemis, there 
have not been any definitive findings that show phosphorylation has any functional 
purpose. Artemis C-terminal phosphorylation-deficient mutants as well as phosphatase-
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treated Artemis all have biochemical endonucleolytic activity. The phosphorylation event 
that seemed to be critical for Artemis activity was the autophosphorylation of DNA-PKcs 
[25, 40, 42]. Phosphorylation-deficient mutants also were able to rescue V(D)J 
recombination defects in Artemis-deficient fibroblasts [38, 40]. They were able to rescue 
the radiation sensitivity of Artemis-null cells, as well [42]. Artemis phosphorylation at 
S516 was correlated being chromatin-bound but this Artemis phosphorylation-deficient 
mutant appeared no different when compared to wildtype in its nuclear distribution [41]. 
These data together all suggest that the phosphorylation of Artemis is not functionally 
important either biochemically or in vivo.  
One possible function for Artemis C-terminus phosphorylation has been 
described more recently [45]. It has been shown previously that cells deficient in the 
homologous recombination (HR) repair pathway proteins, BRCA1 or BRCA2 exhibit 
sensitivity to drug inhibitors for poly ADP ribose polymerase (PARP). PARP proteins are 
involved in base excision repair (BER), a pathway that removes damaged nucleotides 
from the genome. In PARP inhibited cells, single-nucleotide damage resulting from 
reactive oxygen species normally repaired by BER are converted into DSBs during 
transcription or replication. These DSBs are then repaired by HR using the sister 
chromatid. However, HR deficient cells are unable to properly repair these breaks and 
as a result, exhibit sensitivity to PARP inhibitors (PARPi). [46] 
Loss of the two DNA repair factors 53BP1 and PTIP have been shown to rescue 
PARPi-sensitivity of BRCA1-deficient cells suggesting that removal of these two 
proteins restores HR [47]. Wang et al. showed that PTIP associated with Artemis and 
this interaction was dependent on Artemis C-terminus phosphorylation [45]. Like PTIP 
and 53BP1, loss of Artemis rescued PARPi-sensitivity in BRCA1-deficient cells. These 
cells remained resistant to PARPi when an Artemis C-terminal phosphorylation-deficient 
mutant was expressed. The authors speculated that recruitment of PTIP and Artemis to 
sites of DNA damage prevented HR and promoted NHEJ. This recruitment of Artemis 
depended on Artemis C-terminal phosphorylation.  
This latest finding suggests a functional role for the phosphorylation of the 
Artemis C-terminus that is revealed in BRCA1-deficient cells. However, it is unclear 
whether this function would be important during V(D)J recombination. Earlier studies did 
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not find a role for Artemis C-terminal phosphorylation in DNA repair or V(D)J 
recombination. It is possible that the defect of phosphorylation-deficient mutants in 
earlier studies were masked because of their overexpression. While the loss of Artemis 
phosphorylation may not completely abrogate localization or its activity in DNA repair or 
V(D)J recombination, these results do not exclude the possibility that phosphorylation 
may have more subtle roles that would be apparent  if the mutant proteins were 
expressed from an endogenous promoter.  
The structure-function analyses of Artemis have indicated that the interaction 
between Artemis and DNA-PKcs has some functional importance. Soubeyrand et al. 
determined that the amino acids L401 and L402 or Artemis were important for DNA-
PKcs interaction (Figure 1.8) [41]. Mutating these two sites abrogated in vitro 
phosphorylation by DNA-PKcs and reduced phosphorylation in vivo by 2-fold. However, 
this group found that their Artemis L401G/L402N mutant facilitated V(D)J recombination 
of a plasmid substrate in Artemis-deficient fibroblasts. A later study used this same 
mutant in a similar assay using Artemis-deficient human pre-B cells and found that loss 
of the DNA-PKcs interaction domain did negatively impact V(D)J recombination 
frequency about 2-fold [48]. The difference in findings demonstrates that cellular 
environment may influence ex vivo V(D)J recombination assays.   
Other groups and our lab have shown that the loss of the Artemis C-terminus 
negatively impacts biochemical endonuclease activity illustrating that this domain is 
important for promoting activity [44, 49]. However, the C-terminal domain seems to be 
important for promoting activity in the presence of DNA-PKcs but also inhibiting activity 
when DNA-PKcs is absent. Wildtype Artemis nuclease has no activity until it is in the 
presence of DNA-PKcs. However, loss of the entire Artemis C-terminal domain has 
been reported to result in a low level of DNA-PKcs-independent activity [44, 49]. Thus, 
the Artemis C-terminus may normally function to inhibit the catalytic activity and 
interaction with DNA-PKcs relieves this inhibition. How the Artemis C-terminus may 
promote activity is unclear. Biochemical studies mentioned above using Artemis 
phosphorylation-deficient mutants indicate that phosphorylation itself does not affect 
nucleolytic activity. And so the Artemis C-terminus may have structural importance in 
promoting DNA cleavage possibly by stabilizing interaction with the DNA substrate. 
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B lymphocyte development 
The development of B and T lymphocytes is a highly regulated process. The 
timing of Rag generated breaks is coordinated with the different stages of lymphocyte 
development (Figure 1.6) [50]. Hematopoietic stem cells in the bone marrow 
differentiate into lymphoid progenitors and these progenitors go on to develop into B 
cells or migrate to the thymus and develop into T cells. The B cell immunoglobulin 
consists of four components, two identical heavy chain proteins and two identical light 
chain proteins. Rearrangements to produce the heavy chain occur first during the pro-B 
cell stage. At the heavy chain locus, recombination of the DH and JH segments occurs 
and is then followed by the VH segment joining to the recombined DHJH segment. 
Transcription of this region followed by RNA splicing and translation generates a heavy 
chain with a V,D, and J segment and a constant region that is present on all newly 
formed heavy chains (Cμ). This constant region of the heavy chain protein determines 
the isotype of the antibody. In humans, there are five antibody isotypes, IgG, IgA, IgM, 
IgD, and IgE. The biological properties and distribution of antibodies are determined by 
its isotype. For instance, IgM, important for fungal and bacterial infections, is primarily 
found in serum. [51, 52] 
The generation of the heavy chain is followed by light chain rearrangement. Light 
chains are encoded by one of two multigene families, kappa (κ) and lambda (λ). The κ 
light chain rearranges first. This event only involves the Vκ and Jκ segments as light 
chains do not have D segments. If the rearrangement of the κ light chain is successful, 
the B cell then expresses immunoglobulin consisting of a heavy chain (IgH) and a κ light 
chain (IgLκ). In the event that κ rearrangement is unsuccessful, the λ light chain genes 
are rearranged. [52]  
There are numerous V, D, and J segments in the recombining loci. For example, 
the murine heavy chain locus has 134 VH segments, 13 DH segments, and 4 JH 
segments. The rearrangement of the various segments represents one level of 
variability that can be generated during this process. Deletions and additions of 
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nucleotides at the junction between joined segments provide yet another level of 
diversity. [52] 
Although junctional diversity can increase receptor variability, it can also increase 
the likelihood of an unsuccessful rearrangement. Depending on what and how many 
nucleotides are added to the junction, this can either generate a productive join or an 
early stop codon and a nonproductive join. However, because the genome contains two 
copies of each loci, rearrangements at the second allele are initiated if rearrangement at 
the first locus is nonproductive. In addition, because there are two multigene light chain 
families, λ light chain rearrangements will begin if both κ light chain loci recombine 
nonproductively. In the event that both heavy chain rearrangements or both κ and λ light 
chain rearrangements are nonproductive, the cell undergoes programmed cell death. 
[52] 
To prevent the expression of more than one recombined immunoglobulin, 
recombination of the second allele should only be initiated if the first one was 
unsuccessful. One model that explains the suppression of the second allele, or allelic 
exclusion, is the feedback inhibition of recombination by the immunoglobulin protein. 
Support for the feedback inhibition model has been demonstrated in mice expressing an 
Ig transgene. These transgenic mice do not rearrange their Ig loci suggesting the 
expression of Ig protein suppresses recombination. [53] 
B-lymphocytes that successfully undergo heavy chain and light chain 
rearrangement then leave the bone marrow. These cells then migrate to the lymph node 
and spleen where the variable regions of the heavy chain and light chain locus are 
further diversified by somatic hypermutation. During this process, point mutations, 
insertions, and deletions are targeted to the rearranged V, D, and J segments. These 
mutations can either increase or decrease their affinity toward antigen which in turn, 
plays a role in the selection process of B cells. [52] 
T lymphocyte development 
There are many parallels between the development of B cells and T cells. T cells 
begin their lives as lymphoid progenitors in the bone marrow and migrate to the thymus 
(Figure 1.6). Like B cells, rearrangements in T cells is highly regulated and ordered. T 
cells can be categorized as αβ T cells or γδ T cells depending on whether they express 
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the αβ receptor or the γδ receptor on their cell surface. Analogous to the heavy chain 
and light chain found in B cells, the T cell β chain δ chain is comprised of V, D, and J 
segments while the α and γ chains are comprised of V and J segments do not have D 
segments. [52] 
Rearrangements in T cells begin in the double negative stage, a name which 
refers to the lack of either co-receptors CD4 and CD8 displayed on the cell surface. Dβ 
to Jβ rearrangements at the β-chain occurs first and is followed by Vβ to DβJβ 
recombination. Cells that are unable to productively rearrange both alleles of their β-
chain undergo apoptosis. After successful rearrangements at the β-chain, the TCRβ 
protein is expressed. This protein then associates with a pre-Tα chain protein together 
forming the pre-T-cell receptor or pre-TCR. The pre-TCR initiates signaling pathways 
that suppresses further TCRβ chain rearrangements and promotes the rearrangement 
of the TCRα chain. The cell then enters the double positive cell stage (CD4+ CD8+) and 
initiates V to J α chain rearrangement. After successful recombination of the TCRα 
chain, the T cell then enters the single positive stage where they are either expressing 
CD4 or CD8 on the cell surface. Unlike BCRs, TCRs do not undergo somatic 
hypermutation but do exhibit the same types of junctional diversity seen in BCRs.[52] 
γδ T cells rearrange both the γ and δ chain in the double negative stage. 
Rearrangement of the γ, δ, and β chain is thought to occur within a similar timeframe. 
DSBs have been observed at all three loci in the same cell in wildtype thymocytes 
suggesting that at least some of the time, rearrangements at the three loci occur 
simultaneously [54]. It is unclear how the cell determines whether to develop into a γδ T 
cell or an αβ T cell but there is some evidence showing that this decision may be 
determined even before rearrangements at any loci. One group found that in 
developmental stages before rearrangement, cells expressing high levels of interleukin-
17 receptor (IL-17R) are more likely to become γδ T cells and cells with low levels of IL-
17R more likely to become αβ T cells [55].  
B and T cell selection 
The survival of lymphocytes depends on many factors. Rearrangements must be 
productive, generating a functional protein product. Another requirement for the survival 
of lymphocytes is that they cannot bind to self-antigens. This process of removing 
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lymphocytes recognizing self-antigens is referred to as negative selection. The negative 
selection of B cells occurs in the bone marrow. B lymphocytes with BCRs that bind to 
self-antigens are programmed for cell death (clonal deletion) or become unresponsive 
(anergic). However, B cells that bind to self-antigens in the bone marrow can undergo 
receptor editing. In this process, V(D)J recombination is initiated again at the light chain 
to produce another immunoglobulin, potentially with no reactivity to self-antigens. B cells 
that leave the bone marrow and may bind to self-antigens that were not present in the 
bone marrow and will undergo clonal deletion or become anergic. [56] 
Unlike B cells, most T cells cannot recognize antigen without its presentation by a major 
histocompatibility complex (MHC) protein. As a consequence, developing T cells 
encounter two types of selection, positive selection and negative selection. During 
positive selection, thymic stromal cells, macrophages, and dendritic cells in the thymus 
present MHC protein to developing thymocytes. The ability to bind this protein promotes 
survival. During negative selection, dendritic cells and macrophages in the thymus 
present developing T lymphocytes with MHC protein and self-antigen. Thymocytes that 
bind to MHC alone or MHC with self-antigen are also programmed for cell death. 
Surviving cells then go on to the single positive stage where they are either expressing 
CD4 or CD8 on the cell surface.[52]  
Artemis C-terminal domain 
Most human patients with Artemis related RS-SCID have mutations in the N-
terminus of the protein (Figure 1.7) [57]. Mutations in this domain often result in loss of 
the protein or protein activity and these patients are characterized by an absence of B 
and T cells. Patients with mutations in the Artemis C-terminus have also been reported. 
Cell-based V(D)J recombination assays expressing C-terminal truncated Artemis 
protein have previously suggested that this domain is not important for V(D)J 
recombination [38]. However, human patient disease alleles have indicated that loss of 
the C-terminus has detrimental effects on lymphocyte development, immunity, and the 
prevention of tumorigenesis.  
Moshous et al. have reported four patients with Artemis C-terminal truncation 
mutants [58]. Three of these patients had a 7 nucleotide deletion at aspartic acid 451 
leading to a premature stop codon 10 amino acids downstream. On their second allele, 
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these patients had a genomic deletion of exons 1-3 resulting in no mRNA expressed. 
One of the four patients was a homozygous mutant with 17 nucleotides deleted at 
threonine 432 resulting in a premature stop codon 15 amino acids downstream. These 
four patients had mutations that resulted in the loss of most of the C-terminal domain. 
The Artemis C-terminal truncation mutant patients all had B and T 
lymphocytopenia. Two of the patients died from infection and the two others succumbed 
to Epstein-Barr virus (EBV)-associated B cell lymphoma. Patient fibroblasts did not 
facilitate V(D)J recombination of a plasmid substrate and were sensitive to ionizing 
radiation. The patient phenotypes and the phenotypes of their fibroblasts illustrated that 
the Artemis C-terminal domain does have functional roles in V(D)J recombination and 
DNA repair. It is likely that in cell-based V(D)J recombination assays done in the past 
using plasmid-expressed mutant Artemis may have overexpressed the nuclease. 
However, the human patients and patient fibroblasts expressing Artemis from an 
endogenous promoter were able to reveal important functional roles of the C-terminus.  
In order to better understand the function of the C-terminus, our lab generated a 
Artemis mutant mouse modeled after a human patient allele which we refer to as 
Artemis-P70 [49].(Figure 1.8) This Artemis-P70 mouse has a premature stop codon 
introduced to aspartic acid 449, the murine site orthologous to the human D451. We 
have previously reported that our Artemis-P70 mouse, like the human patients, have 
reduced B and T lymphocyte numbers. Artemis-P70 murine fibroblasts are sensitive to 
ionizing radiation and bleomycin demonstrating the importance of the C-terminus in 
DNA repair. Our lab has also aged the Artemis-P70 mice and found that 2 of 14 
succumb to thymic lymphoma during the course of the 40 week observation period [59]. 
Together, these findings illustrate that the Artemis C-terminal domain plays important 
roles in lymphocyte development, DNA repair, and the prevention of tumorigenesis.  
Ataxia-telangiectasia mutated (ATM) 
 Ataxia-telangiectasia mutated (ATM) is a serine/threonine protein kinase that is 
mutated in patients with ataxia-telangiectasia (A-T). A-T patients are characterized 
neural degeneration, ataxia, oculocutaneous telangiectasias, mild immunodeficiency, 
premature aging, and sensitivity to ionizing radiation [60]. Lymphocytes from most A-T 
patients harbor chromosomal translocations and about 10% of patients develop 
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lymphoid malignancies [61]. ATM deficient mice have been generated to study this 
kinase in vivo [60, 62]. Like the patients, these mice exhibit mild immunodeficiency and 
sensitivity to ionizing radiation. Unlike in human patients, neurological effects of ATM 
deficiency are very mild [60]. In addition, nearly all the mice succumb to thymic 
lymphoma within 2 to 4 months.  
This kinase plays a central role in initiating cell cycle arrest and DSB repair. Cells 
deficient in ATM have defective G1/S, intra-S, and G2/M checkpoints [63] and are also 
radiosensitive [61]. About 10% of DSBs seem to require ATM for proper repair [43]. The 
MRE11-RAD50-NBS1 (MRN) complex is thought to sense DSB ends which then 
recruits and activates ATM. Inactive ATM exists as a homodimer but when activated, 
dissociates into monomers [64]. Upon activation, ATM phosphorylates itself as well as 
about 700 other substrates [65]. A few substrates of note include the cell cycle factors 
CHK2 kinase and p53 and the repair factors MRN the histone H2AX.  
ATM has been shown to be important for the prevention of aberrant events 
during V(D)J recombination [66]. Bredemeyer et al. showed that pre-B cells deficient in 
ATM accumulated aberrant hybrid joins, a V(D)J joining event between a coding end 
and a signal end. Similar results were found when cells were treated with the ATM 
kinase inhibitor KU-55933 suggesting that it was the kinase activity of ATM that is 
important for preventing aberrant events. The same group later reported that MRN-
deficient pre-B cells exhibited a similar phenotype with increased aberrant hybrid joining 
when cells were induced to undergo V(D)J recombination [67]. The authors speculated 
that ATM and the MRN complex may be important for stabilizing the post-cleavage 
complex (PCC), a complex of proteins thought to be necessary for the synapsis of DNA 
ends after Rag cleavage. RAD50 protein has been shown to have a “hook domain” that 
can interact with the hook domain of another RAD50 protein [68] and MRE11 was found 
to form homodimers that can bind and align DNA ends, facilitating repair [69]. In 
addition, ATM has been shown to phosphorylate the three components of the MRN 
complex [65]. The authors hypothesized that ATM phosphorylates members of the MRN 
complex which regulates the DNA synapsis functions of this complex. Loss of either 
factors, the MRN complex or the ATM kinase activity, results in a destabilized PCC and 
coding ends are released with some of them engaging in aberrant rearrangements.  
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As mentioned above, the ATM kinase can phosphorylate the Artemis protein and 
seems to be the primary kinase for this event during recovery from ionizing radiation 
[42, 43]. However, the function of this phosphorylation event is unclear. There have 
been some reports that suggest Artemis may function epistatically to ATM in the repair 
of ionizing radiation-induced DSBs [43]. Loss of either factor in fibroblasts results in 
similar levels of unrepaired breaks after treatment with ionizing radiation. In addition, 
inhibition of ATM kinase activity with KU-55933 in Artemis-null fibroblasts did not 
increase levels of unrepaired breaks after ionizing radiation. This same group later 
reported that Artemis nuclease activity is important in homologous recombination during 
G2 and this event is mediated by ATM [70]. The authors suggest that while most breaks 
are repaired in NHEJ in both G1 and G2, heterochromatin associated DSBs in G2 may 
require ATM and Artemis to process DNA ends prior to resection and initiation of 
homologous recombination. 
Although there is evidence that ATM and Artemis may function epistatically in the 
repair of ionizing radiation induced breaks, it remains unclear whether ATM and Artemis 
may function in the same pathway during V(D)J recombination. It has been shown 
before that ATM cannot activate Artemis endonucleolytic activity in biochemical assays 
[25]. However, we have noted phenotypic similarities between our Artemis-P70 mice 
and ATM-/- mice. Because both mice exhibit a mild lymphocyte deficiency and a 
predisposition to thymic lymphoma, it is tempting to speculate that ATM and Artemis 
may function epistatically in the prevention of aberrant rearrangements and loss of 
either factor may result in impaired lymphocyte development and tumorigenesis.   
 
In this study, I further explore the role and regulation of the Artemis nuclease 
both in vitro and in vivo. In Chapter 2, I investigate the factors that are important for the 
regulation of Artemis during V(D)J recombination and examine the consequences of the 
loss of regulation. My findings suggest that the Artemis C-terminus may have important 
roles in the prevention of aberrant rearrangement events and that the DNA-PKcs 
interaction domain may contribute to PCC stability. Results from Chapter 2 also suggest 
that there may be features of the Artemis N-terminal domain outside of its already 
established nuclease activity that may facilitate V(D)J recombination.   
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 In Chapter 3, I examine the relationship between the ATM kinase and the 
Artemis C-terminus in vivo. Analyzing Artemis-P70 ATM-/- mice, I find that the loss of 
both ATM and the Artemis C-terminus have an additive impact on lymphocyte 
deficiency but unlike ATM-/- mice or Artemis-P70 p53-/- mice, none of these mice 
develop tumors. Instead these mice exhibit a susceptibility to colitis. These findings 
suggest that ATM and the Artemis C-terminus cooperate to facilitate lymphocyte 
development and the severe but not total loss of lymphocyte populations may promote 
chronic inflammation in the large intestine.   
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Figures 
 
Figure 1. 1 The B-cell receptor (BCR) and the T-cell receptor (TCR). A) The BCR consists of 
both a light chain (in blue) and a heavy chain (in green). The variable region of the receptor is 
outlined in red. B) The TCR consists of two chains. Shown is a depiction of the αβ receptor with 
the α-chain in beige and the β-chain in dark blue. The variable region is outlined in red. 
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Figure 1. 2 V(D)J recombination.  V, D, and J segments are joined to generate the variable 
region of the antigen receptor. D and J segments are recombined first followed by V to DJ 
rearrangement. Janeway et al. was used as a source for making this figure [71]. 
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Figure 1. 3 Rag capture of 12RSS and 23RSS. The Rag endonuclease (grey ellipse) binds 
one RSS (triangle) and may nick the DNA creating a 3’ hydroxyl group. The Rag complex then 
captures the partner RSS and nicks the DNA at the second RSS. A nucleophilic attack on the 
second strand is catalyzed creating two closed hairpin coding ends. 
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Figure 1. 4 Rag generated ends are joined by the NHEJ pathway. The Rag endonuclease 
creates a DSB at the junction between the RSS (triangle) and the gene segment (rectangle). 
This generates a closed hairpin coding end adjacent to the gene segment and a blunt signal 
end. These ends are then handed off to the NHEJ pathway. KU70 and KU80 (grey ellipse) bind 
to the DNA ends and recruit DNA-PKcs. DNA-PKcs then recruits Artemis (peach sphere) which 
opens the hairpin ends. Coding ends are then joined by the LIG4/XRCC4/Cernunnos ligation 
complex. 
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Figure 1. 5 The mammalian SNM1 family of nucleases. Shown here are the three human 
SNM1 nucleases. The three members of the SNM1 family of proteins share two conserved 
domains, the metallo-β-lactamase domain and the β-CASP domain. Each member also has 
regions of the proteins that are unique (white regions). Sengerova et al. was used as a model 
for this figure [72]. 
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Figure 1. 6 B and T cell development. B and T lymphocytes both arise from hematopoietic 
stem cells in the bone marrow. T lymphocyte progenitors migrate to the thymus and undergo 
V(D)J recombination. During the double negative stage (CD4-CD8-), Rag is expressed and the 
TCRβ chain is rearranged. Double negative cells that successfully rearrange the TCRβ chain 
proceed to the double positive stage (CD4+CD8+) where rearrangement of the TCRα chain 
occurs. Developing T cells then undergo positive and negative selection in the thymus. 
Surviving T cells then migrate to the peripheral tissues as single positive T cells (CD4+ or 
CD8+). B cells undergo V(D)J recombination in the bone marrow. Rag expression is initiated at 
the pro-B cell stage (CD43+B220+) where the Ig heavy chain is rearranged. Cells that 
successfully rearrange this locus proceed to the pre-B cell stage (CD43-B220+) when the Ig 
light chain is rearranged. These B cells then undergo negative selection in the bone marrow. 
Cells that survive this process then migrate to the periphery as a naïve B cell (IgM+B220+).  
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Figure 1. 7 Artemis human patient alleles. The majority of Artemis human patient alleles that 
have been reported have mutations in the N terminal domain of Artemis. The N-terminal 
domain, which constitutes the catalytic core of the protein, is coded by exons 1 -13. The last 
exon, exon 14, codes for the C-terminal domain. Some patient mutations have been reported to 
occur in this domain. This project focuses on a particular allele which we refer to as Artemis-P70 
and is the result of a 7 nt deletion at aspartic acid 451 (mutation number 28 in this figure and 
highlighted in red). This figure was adopted and modified from Pannicke et al. [57]. 
  
29 
 
 
Figure 1. 8 Features of the Artemis protein. Shown here are depictions of human wildtype 
Artemis and human mutant D451fsX10 Artemis protein. Wildtype Artemis has 8 SQ 
phosphorylation sites at its C-terminus including 6 that are clustered together. This domain has 
also been found to interact with DNA-PKcs (L401, R402) and LIG4 (W489). Most human patient 
mutations in Artemis occur within the metallo-β-lactamase domain or the β-CASP domain. 
However, mutations at the C-terminal domain have also been reported. The Artemis-P70 human 
patient allele contains a 7 nucleotide deletion at D451 that results in an early stop codon 10 
amino acids downstream. Patients with this allele lose most of the C-terminal domain, the 8 
phosphorylation sites, and the LIG4 interaction region.  
 
 
 
 
30 
 
 
 
Chapter 2 
The Regulation of Artemis During V(D)J Recombination 
Abstract 
The Artemis nuclease has important DNA end-processing roles in double-
stranded break repair and V(D)J recombination. Disruptions in this gene can result in 
severe combined immunodeficiency and radiosensitivity (RS-SCID). Artemis 
hypomorphic mutations involving the C-terminal domain have been described and these 
patients have been reported to be predisposed to lymphoid malignancies. Here, we 
investigate the factors involved in the regulation of the Artemis nuclease as well as the 
consequences of the loss of regulation. First, I examine the role of the Artemis C-
terminus in regulating endonucleolytic activity and proper V(D)J recombination. I define 
a region of the Artemis C-terminal domain that is critical for endonucleolytic activity and 
also demonstrate that the C-terminus prevents aberrant V(D)J recombination possibly 
through interaction with the DNA dependent protein kinase catalytic subunit (DNA-
PKcs). In addition, I show that the Artemis C-terminus and the ataxia telangiectasia 
mutated (ATM) kinase work cooperatively to prevent these aberrant products. 
In this chapter, I also describe findings that suggest that there may be regulatory 
features in the conserved N-terminal domain of Artemis that have yet to be defined. I 
describe two previously unreported regions of the Artemis N-terminus that were 
important for endonucleolytic activity and also characterize three Artemis mutants based 
on human patient alleles using cellular and biochemical approaches. Results from this 
project indicate that phenotypes observed in two human patients may have resulted 
from protein destabilization. Together, these findings illustrate that loss of Artemis 
regulation can result in a dysfunctional protein that can catalyze aberrant 
rearrangements. In addition, these results suggest that there may be other regulatory 
domains in the Artemis N-terminus that can facilitate V(D)J recombination.  
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Introduction 
B and T cell antigen receptors must be able to recognize and bind to a myriad of 
substrates including foreign molecules and pathogens. In order to create this level of 
diversity in antigen receptors, developing B and T cells employ a gene rearrangement 
strategy referred to as V(D)J recombination. V(D)J recombination occurs during early 
lymphocyte development and these rearranged gene segments go on to encode the 
variable regions of antigen receptors. Adjacent to the gene segments are recombination 
signal sequences (RSSs) recognized by the Rag endonuclease. The Rag endonuclease 
comprising of the two proteins RAG1 and RAG2, initiates recombination by creating a 
single stranded nick at the junction between the RSS and the gene segment creating a 
3’ hydroxyl group. This hydroxyl group acts as a nucleophile and attacks the second 
strand, creating a double-stranded break (DSB) with one hairpin-sealed coding end and 
a blunt signal end. In order to join two different gene segments, the hairpin coding ends 
must be cleaved open. The Artemis nuclease and the serine/threonine protein kinase 
DNA-PKcs were found to be required for opening these hairpin ends during V(D)J 
recombination [1].  
Artemis belongs to the SNM1 family of proteins which includes the nucleases 
Snm1A and Snm1B. These three proteins all have the metallo--lactamase and CASP 
domain which together form the catalytic domain of the protein. The Artemis protein also 
has a C-terminal domain that is unique among its family members. This C-terminal 
domain was found to be important for interacting with DNA-PKcs and the 
nonhomologous end-joining ligase, LIG4 [2, 3].  
Human patients with Artemis C-terminal truncations have been reported in the 
literature. Three human patients reported were found to have a 7 nucleotide deletion 
that resulted in a frameshift at aspartic acid 451 and an early stop codon 10 amino acids 
downstream (patient allele referred to as P70). The second allele of these patients, a 
deletion of exons 1-3, did not produce mRNA. These patients were found to be 
immunodeficient with low B and T lymphocyte counts. Additionally, human patient 
fibroblasts were sensitive to ionizing radiation. Because immunodeficiency and ionizing 
sensitivity was not as severe as human patients with mutations in the catalytic domain, 
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this mutant was categorized as hypomorphic. Strikingly, two of the three patients 
succumb to Epstein-Barr virus (EBV)-associated B cell lymphoma. These B cell 
proliferations were had clonal IgH rearrangements and lymphocytes from these patients 
harbored chromosomal alterations. Together, these findings suggested the 
malignancies were at least partially driven by genomic instability. The patient 
phenotypes indicated that the Artemis C-terminus may have roles in V(D)J 
recombination, DNA repair in response to ionizing radiation, and preventing lymphoma. 
[4] 
We have previously generated an Artemis-P70 mouse model by introducing a 
stop codon at aspartic acid 449 of the endogenous murine Artemis gene. Like their 
human patient counterparts, these mice exhibited reduced numbers of B and T cell 
lymphocytes with fibroblasts sensitive to ionizing radiation. Additionally, two of fourteen 
Artemis-P70 mice succumb to lymphoma within 40 weeks. When this mutation is 
combined with a p53-null background, all mice succumbed to lymphoma. Moreover, 
Artemis-P70 p53-/- mice die significantly earlier than p53-null single mutant mice. These 
tumors harbored clonal rearrangements as well as translocations involving the antigen 
receptor rearranging loci. Together, these data strongly implicate the Artemis C-
terminus in V(D)J recombination and preventing tumorigenesis. [5, 6] 
Rag-generated DNA ends are held together by a protein-DNA complex referred 
to as the post-cleavage complex (PCC). The Rag endonuclease itself is thought to be 
important for preventing both the loss of DNA ends and aberrant rearrangements. 
Cleavage at RSS has been shown to only require the “core” Rag proteins, the C-
terminal domain of RAG1 and the N-terminal domain of RAG2. The non-core N-
terminus of RAG1 has been shown in biochemical assays to be dispensable for 
cleavage of a RSS substrate but was important for the retention of hairpin ends in the 
PCC [7]. Another group similarly showed biochemically that the RAG2 C-terminus was 
important for the retention of coding and signal ends in the PCC. Supporting the idea 
that the RAG2 C-terminus is important for preventing loss of DNA ends, splenocytes 
from core-RAG2 mice also had increased aberrant rearrangements [8].  
The ability of the RAG1 point mutants S723A and S723C in supporting stable 
PCC have also been studied biochemically. Tsai et al. found that PCCs consisting of 
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RAG1 point mutants did not bind to DNA ends as well as wildtype protein. [9] Our lab 
has generated the Rag1 S723C point mutant mouse and found that this mouse exhibits 
impaired V(D)J recombination in vivo and in addition, thymocytes from these mice 
displayed increased aberrant rearrangements. When these mice were crossed into a 
p53-null background, double mutant mice succumbed to thymic lymphomas that 
frequently had clonal translocations making these thymic lymphomas distinct from p53 
single mutant lymphomas [10]. Together, these results indicate that the RAG proteins 
have important roles maintaining PCC stability and that loss of stability can result in 
aberrant rearrangements and tumorigenesis. 
In addition to the Rag endonuclease, other proteins are also thought to be 
important for preventing aberrant rearrangements by stabilizing the post-cleavage 
complex. Ataxia-telangiectasia mutated (ATM) is a serine/threonine protein kinase that 
is mutated in patients with ataxia-telangiectasia. This kinase has important roles in cell 
cycle regulation as well as DSB repair. Using ATM-null murine pre-B cells, Bredemeyer 
et al. observed aberrant rearrangement events when these cells were induced to 
undergo V(D)J recombination [11]. The treatment of these cell lines with the ATM 
kinase inhibitor KU55933 yielded similar results suggesting it is the kinase activity of 
ATM that is important for preventing aberrant V(D)J events. 
The MRE11-RAD50-NBS1 (MRN) protein complex has also been suggested to 
be important for PCC stability. This protein complex has roles in DSB repair as well as 
efficient activation of the ATM kinase. Using cell lines expressing hypomorphic Mre11 
and Nbs1, the Helmink et al. found that MRN-hypomorphic cell lines had increased 
aberrant recombination products similar to results seen in ATM deficiency. [12] 
Our characterization of the Artemis-P70 mouse model has led us to suspect that 
the Artemis C-terminal domain may be important for maintaining post-cleavage complex 
stability [5, 6]. Lymphocytes from Artemis-P70 mice accumulate coding ends and 
display increased aberrant rearrangements at antigen receptor loci. We have also found 
that Artemis-P70/p53 mice succumb to lymphoma with translocations involving 
rearranging loci. In this study, we further characterize the roles of the Artemis C-
terminus during V(D)J recombination and examine what factors are important for proper 
rearrangement. We identified a part of the Artemis C-terminal domain that is important 
34 
 
for full endonucleolytic activity and that the C-terminus is important for the prevention of 
aberrant rearrangements. We did not find that loss of the Artemis C-terminus altered 
ATM activation or MRN stability. However, loss of the DNA-PKcs interacting domain 
further increased aberrant rearrangements. In this study, we also discovered previously 
uncharacterized regions of the conserved N-terminal domain that are important for 
endonucleolytic activity. 
Results 
The proximal region of the Artemis C-terminus is important for endonucleolytic 
activity 
We and other labs have previously shown that the Artemis C-terminus has 
important roles in regulating Artemis endonucleolytic activity [5, 13]. The C-terminal 
domain has been found to be important for promoting endonucleolytic activity in the 
presence of DNA-PKcs but also seems to inhibit activity in the absence of DNA-PKcs[5, 
13]. To further characterize the regulation of activity by the Artemis C-terminus, several 
Artemis truncation mutants were constructed (Figure 2.1). The ML/CASP construct 
consists of amino acids 1-385 and is missing the entire C-terminus including the DNA-
PKcs and Lig4 interaction domain. The D451X truncation mutant (amino acids 1-451) is 
modeled after the Artemis-P70 human disease mutation and retains the DNA-PKcs 
interaction domain (L401 and R402). The 502-692 truncation mutant includes the both 
the DNA-PKcs and LIG4 interaction domain (W489). The Artemis C-terminus contains a 
cluster of SQ sites between S516 and S562 which are demonstrated to be 
phosphorylated by DNA-PKcs and the ATM kinase [2, 14, 15]. The truncation mutant 
Δ539-692 and Δ599-692 include part or all of the SQ cluster domain. Lastly, the Δ646-
692 mutant includes all the features above plus an additional SQ phosphorylation site 
S645, a site which has been shown in vivo to be phosphorylated by ATM [15]. These 
mutant proteins were expressed in 293T cells and the Artemis proteins were purified 
from DNA-PKcs. Purification from DNA-PKcs and Artemis protein normalization was 
confirmed by Western blot analysis (Figure 2.2, A).  
I analyzed the ability of these mutants to cleave a 32P 5’ end-labeled 40-bp 
hairpin substrate. Cleavage at the apex of the hairpin by Artemis yields a 20 nucleotide 
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product. I found that complete loss of the Artemis C-terminus resulted in low levels of 
DNA-PKcs-independent activity (Figure 2.2, B., second lane). This result corroborates 
with previous findings and supports the notion that the C-terminal domain may have an 
inhibitory function in the absence of DNA-PKcs. Three truncation mutations 
ML/CASP, D451X, and 502-692 were unable to cleave the hairpin substrate at 
levels matching the wildtype Artemis protein. However, the three truncation mutants 
539-692, 599-692, and 646-692 had wildtype levels of nucleolytic activity indicating 
that amino acids 599 to 692 are dispensable for full biochemical activity. This result also 
demonstrates that the C-terminal region between amino acid 385 and 539 contains an 
important region that is critical for nucleolytic activity. Although these three mutants 
include either part of or all of the SQ cluster, it is unlikely that full nucleolytic activity can 
be attributed to the presence of these phosphorylation sites. Past studies using Artemis 
C-terminal phosphorylation-deficient mutants demonstrated that Artemis 
phosphorylation did not seem to be important for biochemical activity [14-16]. It is 
possible that this region may be important for stabilizing interaction with DNA-PKcs or 
the DNA end.  
Increased aberrant rearrangements in Artemis-P70 backgrounds 
Our lab has published results showing in vivo, B and T cells from Artemis-P70 
harbor the products of aberrant V(D)J recombination events [6]. However, B and T cells 
undergo and selection process in vivo and some lymphoid cells that carry out 
nonproductive rearrangements are removed from the population. By utilizing the 
transient assay in MEFs, we can take advantage of the lack of selection process and 
gain a less biased analysis of recombination events. 
We previously reported on the proficiency of the Artemis-P70 protein in 
facilitating V(D)J recombination in the cell-based transient V(D)J assay [5]. We used a 
deletional coding join plasmid substrate containing two RSSs recognized by the Rag 
endonuclease. Cleavage by Rag creates two coding ends that are joined by deleting the 
intervening sequence. We found that while the Artemis-P70 mouse embryonic 
fibroblasts produced coding joins at low frequencies, the joins formed had normal 
nucleotide additions and deletions. In contrast, coding joins formed in Artemis-null 
MEFs typically exhibit larger nucleotide deletions.  
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In address the role of the Artemis C-terminus in recombination at endogenous 
loci, our lab analyzed inversional rearrangements at the IgLκ light chain locus of 
splenocytes [6]. We found that Artemis-P70 splenocytes produced aberrant hybrid joins 
when attempting inversional V(D)J recombination in vivo. The hybrid join observed here 
is an aberrant joining event between a coding end and a signal end. The nature of this 
event indicates that the inversional, intervening sequence has been lost from the PCC. . 
These aberrant products were not detected in Artemis-null lymphocytes. In order to test 
the hypothesis that the Artemis-P70 protein may be more prone to producing aberrant 
products when attempting inversional recombination, we used the inversional 
recombination plasmid substrate pJH299 in the cell-based transient V(D)J assay (Figure 
2.3). Recombination of this substrate to create a signal joint and a coding joint requires 
the retention of the intervening sequence. Like at the IgLκ locus, the loss of the 
intervening sequence can result in the formation of an aberrant deletional hybrid joint. 
Like our previous experiments using the deletional coding join plasmid substrate, 
recombination of the inversional substrate occurred at a low frequency in both Artemis-
null and Artemis-P70 backgrounds (Figure 2.4). However, aberrant deletional hybrid 
joins occurred at a higher frequency in Artemis-null and Artemis-P70 backgrounds 
(wildtype and Artemis-null p < 0.0001, wildtype and Artemis-P70, p < 0.0001, two-tailed 
Fisher’s exact test) (Figure 2.5). Analyzing junctional sequences revealed differences 
between the joins formed in Artemis-null MEFs and Artemis-P70 MEFs (Figure 2.6, 2.7, 
2.8). The majority of joints formed in Artemis-null mice had larger nucleotide deletions 
(11 of 13 inversional joins and 14 of 20 deletional hybrid joins had nucleotide deletions 
larger than 12 nt). Conversely, the majority of joins formed in Artemis-P70 backgrounds 
did not have large deletions (3 of 10 inversional joins and 4 of 17 deletional hybrid joins 
had nucleotide deletions larger than 12 nt). Interestingly, one plasmid recovered from 
Artemis-P70 MEFs was a product of an unexpected aberrant event, joining one signal 
end to the RAG2 gene (Figure 2.7). 
As mentioned above, we previously detected differences in recombination 
frequency using a deletional coding join plasmid substrate in wildtype and Artemis-P70 
MEFs. However, using this inversional recombination plasmid substrate which requires 
the retention of the intervening sequence, we found that V(D)J recombination facilitated 
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by the Artemis-P70 protein resulted in increased aberrant deletional joining frequency 
when compared to wildtype. Recovered recombination substrate from Artemis-P70 and 
Artemis-null MEFs exhibited differences with regard to nucleotide deletions at coding 
and hybrid joints. This result indicated that the Artemis-P70 protein facilitated 
recombination and these joins were distinct from joins facilitated by the yet-
undetermined nuclease utilized in Artemis-null MEFs. Together, these results support 
the hypothesis that loss of the C-terminus destabilizes the PCC. The Artemis-P70 
protein retains the ability to open these hairpin ends, but through a yet undefined 
mechanism, results in the inability of the PCC to retain the intervening sequence.  
Loss of the Artemis C-terminus does not disrupt ATM kinase activity or the MRN 
complex 
Our findings that loss of the Artemis C-terminus results in increased aberrant 
joining in vivo as well as ex vivo using an inversional recombination plasmid substrate in 
the cell-based transient V(D)J assay. These findings regarding Artemis-P70 are similar 
to findings that have been reported for ATM deficiency and MRN deficiency. Loss of 
ATM, ATM kinase activity, or members of the MRN complex result in increased aberrant 
rearrangements and therefore, these factors are thought to be important for PCC 
stability.  
We addressed the impact of loss of the Artemis C-terminus on ATM kinase 
activity and the integrity of the MRN complex. In order to address this issue, Artemis-
P70 MEFs were exposed to 10 grays of ionizing radiation and ATM activation was 
analyzed by Western blotting. Upon exposure to IR, the ATM kinase undergoes 
autophosphorylation and is activated. ATM then phosphorylates downstream substrates 
including the histone variant H2AX and the KRAB-associated protein 1 (KAP1). Our lab 
found that after ionizing radiation, ATM was phosphorylated in both Artemis-null and 
Artemis-P70 MEFs (Figure 2.4, A). In addition, ATM substrates KAP1 and H2AX were 
both phosphorylated in mutant MEF lines (Figure 2.4, B). I found that in Artemis-P70 
MEFs, NBS1 and RAD50 co-immunoprecipitated with MRE11 indicating that the 
presence of the Artemis-P70 protein did not disrupt MRN complex stability (Figure 2.4 
C). Together, these results indicate that in Artemis-P70 backgrounds, the ATM kinase is 
active and the MRN complex is intact.  
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The Artemis C-terminus is important for facilitating chromosomal rearrangement 
and preventing aberrant products 
In order to further characterize the Artemis C-terminal domain in the context of 
V(D)J recombination, C-terminal truncation mutants were expressed in Artemis-null 
murine pre-B cell lines using retroviral transduction. This pre-B cell line has been 
transformed using viral Abelson kinase (v-abl) and in addition, has a chromosomally-
integrated recombination substrate, pMX-INV. Treating these cells with the Abelson 
kinase inhibitor STI571 arrests the cells in G1 phase which in turn results in Rag 
accumulation and the initiation of V(D)J recombination.  
pMX-INV contains two recombination signal sequences that flank an anti-sense 
GFP cDNA. Recombination of this substrate can result in an inversion of the anti-sense 
GFP and creates both a signal join and a coding join. Cells that have undergone an 
inversional event will express GFP. Defective recombination can result in the loss of the 
intervening sequencing and the joining of a signal end and a coding end, a hybrid join. 
DNA ends released from the recombination protein complex could also engage in 
transrearrangements with the DNA ends of another rearranging locus. (Figure 2.10)  
Wildtype Artemis, empty vector, and Artemis mutant constructs ML/CASP and 
D451X were stably expressed in the Artemis-null pre-B cells by retroviral transduction. 
Retroviral construct contained both an Artemis and dsRED2 cDNA separated by an 
IRES sequence. Transduced cells were then sorted for dsRED2 expression and three 
clones of each genotype were chosen for further analysis. RT-PCR and Q-PCR 
demonstrated that Artemis mutant constructs were both being expressed and were 
expressed at levels that allowed comparison between genotypes (Figure 2.11). 
Cell lines were treated with STI571 and harvested at 96 hours post-treatment. 
Genomic DNA was extracted and rearrangements were analyzed using genomic 
Southern blot. As expected, Artemis-null pre-B cells transduced with only the retroviral 
vector did not support V(D)J recombination (Figure 2.12). An accumulation of coding 
ends indicated that treatment of the cells with STI571 induced recombination but DNA 
coding ends did not engage in ligation. Expression of wildtype Artemis in these cells 
rescued the V(D)J deficiency and coding joins were detected by genomic Southern. As 
reported in the literature, treatment of wildtype Artemis expressing pre-B cells with the 
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ATM inhibitor KU55933 resulted in increased hybrid joining and the accumulation of 
coding ends [17].  
Surprisingly, expression of the MβL/βCASP and D451X constructs rescued 
coding join formation to wildtype levels. These findings are in contrast to recombination 
frequency using Artemis-P70 MEFs in the transient V(D)J assay was very low. Artemis 
truncation mutants have low endonucleolytic activity and the MβL/βCASP construct 
does not include the DNA-PKcs binding domain. Yet I observed high levels of coding 
join formation which was likely due to overexpression of the Artemis constructs in these 
cell lines. In contrast, Artemis-P70 MEFs likely expressed the mutant protein at lower 
levels from an endogenous promoter. Results using the pre-B cell system indicated that 
the loss of the Artemis C-terminus resulted in increased hybrid join formation and 
increased coding end accumulation (Figure 2.12). In order to determine whether these 
coding ends can go on to engage in aberrant transrearrangements, nested PCR was 
used to amplify events involving the pMX-INV recombination substrate and the 
endogenous rearranging IgLκ locus (Figure 2.13). Treatment of pre-B cell clones with 
STI571 alone resulted in transrearrangements in MβL/βCASP and D451X expressing 
cells but not in wildtype Artemis expressing cells or Artemis-null cells transduced with 
empty vector. Treatment of these cells with ATM inhibitor KU55933 and STI571 resulted 
in higher levels of transrearrangements than treatment with STI571 alone. 
Expression of either MβL/βCASP or D451X Artemis mutants resulted in 
increased hybrid joining, coding end accumulation, and transrearrangements. We 
observed more aberrant products in pre-B cell lines expressing MβL/βCASP Artemis 
than in pre-B cells expressing the D451X truncation mutant. This difference between the 
two pre-B cell genotypes suggest a PCC stabilizing role for the DNA-PKcs interaction 
domain that is present in the D451X truncation mutant but absent in the MβL/βCASP 
mutant. We also observed that inhibition of ATM kinase activity increased the levels of 
transrearrangements observed in both Artemis mutant pre-B cell lines. This result 
indicates that ATM may be involved in multiple pathways in the stabilization of the PCC 
but does not rule out the possibility of epistasis between ATM and the Artemis C-
terminus specifically in the prevention of aberrant rearrangements. 
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Uncharacterized regions of the conserved N-terminal domain are important for 
Artemis activity 
We and others have found that expression of the conserved MβL/βCASP N-
terminal domain of Artemis in Artemis-deficient cells fully restores V(D)J recombination 
defects in the transient assay [5, 13, 18]. Here, I found that MβL/βCASP expression in 
the pre-B cell system was able to facilitate wildtype-levels of coding join formation 
despite producing aberrant products. This was a surprising result because this mutant 
has very little endonucleolytic activity and does not interact with DNA-PKcs[5, 13]. It is 
likely that the overexpression of this truncation mutant rescued recombination frequency 
but also may have revealed an important aspect of Artemis.  
In this study, we consider the possibility that the MβL/βCASP domain has 
features, outside of its already known catalytic activity, that may aid the protein in 
facilitating V(D)J recombination. To test the idea that simply overexpression of a 
nuclease can rescue V(D)J recombination, we overexpressed SNM1B and MRE11 in 
the transient assay using Artemis-null MEFs. Although both SNM1B and MRE11 have 
both been shown to be capable of cleaving a DNA hairpin substrate [19] neither 
overexpressed proteins were able to facilitate recombination (Figure 2.17, A and B)  
SNM1B, a member of the SNM1 family of proteins along with Artemis, also has 
the metallo-β-lactamase and β-CASP domain. Yet, overexpression of this protein did 
not rescue V(D)J recombination in Artemis-null MEFs. This suggests that the Artemis N-
terminal domain has features that allow it to modify Rag-generated breaks and these 
features are not present in SNM1B. In order to address what these features may be, we 
searched for regions in the amino acid sequence of the Artemis N-terminus that were 
unique to Artemis among its family members. To increase the likelihood that these 
regions are functionally important outside of catalytic activity, we also searched for 
sequences that were well conserved among Artemis orthologs but were not predicted to 
be in regions that were involved with metal coordination.  
To narrow down candidates, we used previously reported human missense point 
mutants to help select regions that could be functionally important. We selected three 
human patient mutants H228N, I16T, and T71P, as a model for making point mutants 
for study (Table 2.1). The patient with the Artemis-H228N mutation and the patient with 
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the Artemis-I16T mutation both exhibited absence of B and T cells [20, 21]. The 
Artemis-H228N patient had a deletion of exon 1-4 on the second allele. The Artemis-
I16T patient had a S119X truncation mutation on the second allele, not likely producing 
a functional protein. Fibroblasts from both patients were sensitive to ionizing radiation. 
The third patient with the Artemis T71P allele interestingly had some T cells and 
fibroblasts from this patient did not exhibit sensitivity to ionizing radiation as analyzed by 
γ-H2AX assay [22]. The second allele in the Artemis-T71P patient contained a deletion 
of exon 1-3.  
A total of five mutations were chosen to be introduced to the MβL/βCASP 
truncation construct (Figure 2.14). All amino acids or motifs chosen to mutate were not 
anticipated to be important for nucleolytic activity based on their positions on a predicted 
structural model of Artemis generated by the SWISS-MODEL program (Figure 2.15). In 
addition, amino acid H228 is predicted to be in a shallow groove that others have 
speculated could be important for DNA binding [23].  
To analyze the endonucleolytic activity of the mutant Artemis constructs, Artemis 
protein was purified from DNA-PKcs and incubated with manganese and either a 32P 5’ 
end labeled DNA overhang substrate or a DNA hairpin substrate. We have previously 
shown that in the presence of manganese, Artemis does not require DNA-PKcs for 
activity [5]. MβL/βCASP-I16A and MβL/βCASP-H228A could not be consistently 
expressed at high enough levels to be analyzed for endonucleolytic activity. This 
suggested that both mutations destabilized the protein and these two regions may have 
structural roles. We found that mutants MβL/βCASP-KRR3A and MβL/βCASP-LHSG4A 
were not able to cleave either the overhang or hairpin substrate (Figure 2.16). However 
the T71A point mutation did not have a negative impact on the ability of the MβL/βCASP 
protein to cleave either DNA substrates. We also did not observe any impact on 
endonucleolytic activity when the T71A point mutation was introduced to the full length 
Artemis protein (FL-T71A). 
The two mutants MβL/βCASP-T71A and FL-T71A were able to facilitate the 
recombination of the inversional recombination plasmid substrate pJH299. 
Recombination frequencies observed in T71A expressing MEFs were comparable to 
wildtype Artemis and MβL/βCASP expressing MEFs (Figure 2.17, B). Recombined 
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products were harvested, sequenced, and joining events were categorized as either 
inversional or deletional (Figure 2.18). We observed increased deletional events in 
MEFs expressing MβL/βCASP when compared to wildtype expressing MEFs (p < 
0.0001, two-tailed Fisher’s exact test). However, T71A mutation in either the 
MβL/βCASP or full length protein did not impact the ratio of inversional to deletional 
events (MβL/βCASP and MβL/βC-T71A, p = 1.000, wildtype and FL-T71A, p = 0.1461). 
We also did not observe any significant differences in nucleotide deletions, additions, or 
microhomologies when the T71A point mutation was introduced to either the 
MβL/βCASP or full length Artemis protein (Figure 2.19, 2.20, 2.21, 2.22). 
Here, we report regions of the Artemis N-terminus, KRR (48-50) and LHSG (150-
153), that are important for endonucleolytic activity or protein stability despite not being 
predicted to be important for metal ion coordination. While we cannot rule out that these 
mutations may alter protein conformation, it is also possible that these two regions may 
be important for contacting or handling DNA ends. Due to low expression levels, we 
were not able to analyze the activity of two constructs that were based on human 
patient alleles, H228A and I16A. It is likely that these two mutations destabilized the 
protein and this is likely the mechanistic explanation for the patient phenotypes (Table 
2.1). Surprisingly, the T71A mutation did not affect biochemical activity or V(D)J 
recombination despite the report that a patient with an Artemis T71P mutant allele 
exhibited lymphopenia [22]. However, our results indicate that this amino acid may not 
be directly involved with activity or recombination but rather the proline substitution in 
the patient may have altered protein conformation and resulted in a hypomorphic 
nuclease. 
Discussion 
We have previously reported that the Artemis C-terminus has important 
functional roles in V(D)J recombination as well as the repair of general DSBs in vivo [5, 
6]. In this study, we further demonstrate that the Artemis C-terminus functions in the 
regulation of the nuclease and the prevention of aberrant events.  
It has been previously shown that the Artemis C-terminus is important for full 
endonucleolytic activity [2, 5, 13]. We show here that the catalytic N-terminal domain 
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combined with the C-terminal region between amino acid 386 and 538 is sufficient for 
full endonucleolytic activity in the in vitro endonuclease assay. The known features in 
this region include the DNA-PKcs binding domain, the LIG4 binding domain, and four 
SQ putative phosphorylation sites (S503, S516, S534, and S538). Because some 
truncation constructs that contain the DNA-PKcs binding domain and LIG4 binding 
domain (D451X and 502-692) do not exhibit full activity, it is tempting to conclude that 
the four SQ phosphorylation sites that are present in the 539-692 construct contribute 
to its endonucleolytic activity. It has been shown previously that Artemis does not need 
to be phosphorylated in order to have endonucleolytic activity and the critical 
phosphorylation event for nuclease recruitment and activity is phosphorylation of DNA-
PKcs [14-16, 24]. Thus, this raises the possibility that this region of the C-terminal 
domain is important for either stabilizing the interaction between Artemis and DNA-PKcs 
or stabilizing the nuclease interaction with DNA itself.  
Artemis-P70 B and T lymphocytes harbor aberrant rearrangements involving the 
rearranging B and T cell receptor locus and these rearrangements were rarely observed 
in Artemis-null cells. We also found that Artemis-P70/p53 mice succumb to lymphoma 
and these tumors were clonal and harbored transrearrangements involving the antigen 
receptor loci. This led us to hypothesize that the Artemis C-terminus may play a role in 
PCC stability. We had previously analyzed the ability of Artemis-P70 MEFs to 
recombine a plasmid substrate. In those experiments we utilized a substrate that 
recombined by deletion of an intervening sequence to create a coding join. We found 
that Artemis-P70 MEFs produced much fewer recombinants but recovered plasmids 
had joint sequences similar to recombinants recovered from wildtype MEFs. In contrast, 
substrate recovered from Artemis-null MEFs exhibited large nucleotide deletions from 
both coding ends.  
In order to better understand the role of the Artemis C-terminus during 
inversional recombination, here we performed the transient V(D)J recombination assay 
using a plasmid substrate that recombines by inverting an intervening sequence 
generating a signal join and a coding join. We observed very low recombination 
frequencies in both our Artemis-null and Artemis-P70 MEFs. This was similar to our 
results using the deletional coding join substrate and likely is due to the low 
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endonucleolytic activity of the Artemis-P70 protein. Like our in vivo results, we found 
that Artemis-P70 facilitated recombination resulted in increased aberrant hybrid joining 
when compared to joins produced in wildtype backgrounds. In vivo, aberrant hybrid 
joins were rare events in Artemis-null. Although, we observed similar levels of hybrid 
joining from our Artemis-null MEFs, the joint sequence from both genotypes were 
distinct suggesting that two different repair mechanisms were at play. Unlike in Artemis-
null MEFs, the majority of joins formed in Artemis-P70 MEFs did not have large 
nucleotide deletions and the signal ends remained unmodified even in hybrid joins. This 
result suggests that the Artemis-P70 protein can process these DNA ends but the PCC 
in these cells is unstable and releases the DNA ends prematurely. Conversely, the PCC 
in Artemis-null MEFs may be further disrupted by an unknown nuclease resulting in 
larger nucleotide deletions at both DNA ends. 
The Artemis C-terminal domain has several sites that can be phosphorylated by 
DNA-PKcs and ATM. Because we know that loss of ATM kinase activity can result in 
aberrant hybrid joining, one simple explanation is that the phosphorylation of the 
Artemis C-terminus plays a role in stabilizing the PCC. Although others have shown that 
Artemis phosphorylation-deficient mutants can facilitate V(D)J recombination at wildtype 
levels, these experiments used plasmids substrates that recombine by deletion to 
generate a coding join [15]. An inversional recombination substrate may reveal PCC 
stability defects in Artemis phosphomutant expressing cells.  
A second, non-mutually exclusive explanation for increased hybrid joining in 
Artemis-P70 backgrounds involves the reduced endonucleolytic activity of the protein. A 
partially active nuclease may cleave only one of two hairpin coding ends in the PCC. 
Unable to join the two ends, the PCC would eventually collapse and the free ends would 
be capable of engaging in aberrant joining. Currently, it is not possible to distinguish 
between the two possibilities or determine if both are at play. One way to address this 
hypothesis in the future would be to identify N-terminal mutations that partially disrupt 
nucleolytic activity. This potential separation-of-function mutant could help define the 
contributions of the Artemis C-terminus and the endonucleolytic activity of Artemis to 
PCC stability.   
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Joins formed in Artemis-null MEFs exhibited large nucleotide deletions on both 
coding ends and signal ends. This result suggests that these ends are processed by a 
currently unknown alternative nuclease that is capable of disrupting the PCC and the 
RAG proteins that are normally tightly bound to signal ends. This result also introduces 
the interesting possibility that the Artemis nuclease may protect signal ends from 
degradation specifically during inversional recombination. However, it has been 
previously shown that loss of the Artemis nuclease does not impact signal join formation 
using a deletional signal join plasmid substrate and Artemis-null ES cells [25]. The 
majority of signal joins produced in Artemis-null ES cells were precise and did not 
exhibit end modification. Another report that examined signal joining at the endogenous 
recombination locus in thymocytes found that the loss of Artemis resulted in fewer 
nucleotide deletions at signal joins when compared to wildtype thymocytes [26]. These 
two findings from two separate studies illustrate the different ways DNA ends are 
processed in different environments. The enzymes and nucleases that are differentially 
expressed in various cell types may contribute to the contradicting observations.  
Although the Artemis mutant constructs were overexpressed in the pre-B cell 
system, we were able to take advantage of this experimental system to further shed 
light on the Artemis C-terminus in V(D)J recombination. As expected, pre-B cells 
expressing the Artemis-P70 protein D451X produced aberrant hybrid joins when 
induced to recombine. We and others have shown that expression of the MβL/βCASP 
construct can rescue V(D)J recombination deficiencies of Artemis-null backgrounds. 
Here, we show for the first time that although MβL/βCASP can restore recombination, it 
also facilitates the generation of aberrant hybrid joins and coding end accumulation. The 
amount of these aberrant products was higher than in D451X expressing clones. This 
result suggested that the PCC was even more unstable in our lines expressing 
MβL/βCASP than in lines expressing D451X. One domain that is present in the D451X 
construct but absent in the MβL/βCASP construct is the DNA-PKcs interaction domain. 
It is possible that the there are several factors that contribute to PCC stability and this 
interaction between Artemis and DNA-PKcs is one of the requirements for stability 
The expression of MβL/βCASP can facilitate V(D)J recombination despite its very 
low endonucleolytic activity. It is assumed that this is the consequence of mutant 
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overexpression as all prior experiments testing the protein for V(D)J recombination 
capabilities have used transient transfection. We hypothesized that the conserved 
domain of Artemis has features, aside from catalytic activity, that are unique to this 
nuclease and allow it to facilitate cleavage of Rag-induced hairpin ends. Supporting this 
idea, overexpression of SNM1B or MRE11 did not support V(D)J recombination in the 
absence of Artemis. However, in this study, we could not identify regions that disrupted 
V(D)J recombination but not endonucleolytic activity. We were able to identify two 
previously undescribed regions, KRR (48-50) and LHSG (150-153), that were important 
for endonucleolytic activity. Although it we have not ruled out the possibility that these 
mutations could alter protein conformation, these two regions could potentially be 
important for contacting DNA during cleavage. 
Two amino acids studied H228 and I16, were expressed at very low levels in the 
transient expression system suggesting these sites are important for protein stability. It 
is possible that protein instability contributed to or perhaps was even solely responsible 
for the patient phenotypes observed (Table 2.1, [20], [21]). However, our results do not 
exclude the possibility that these sites may also have other functions. For instance, in 
addition to its role in protein stability, H228 has been predicted to be in a groove that 
may be important for binding to DNA [23]. The presence of this feature may suggest 
that the Artemis N-terminus may be binding to DNA substrates directly and that Artemis 
truncation mutants may depend of this feature for activity.  
We did not detect an effect of the T71A mutation on either the MβL/βCASP or full 
length Artemis protein. T71A mutants readily cleaved the overhang and hairpin 
substrate and facilitated V(D)J recombination without increasing aberrant events. Yet, 
the patient with a T71P mutation exhibited lymphocytopenia. The original study 
sequenced the RAG1 and RAG2 genes in addition to Artemis [22]. One possibility is 
that the patient lymphocytopenia was not the caused by any of the three genes 
analyzed and the T71P mutation was an undisruptive variant. While this possibility 
cannot currently be ruled out, the evolutionary conservation of T71 and its location on 
the electropositive surface of the protein suggests it may be functionally important and 
may even participate in DNA binding [27].  
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In order to understand the role of this particular T71 site, we used an alanine 
substitution, a small, inert amino acid that would be less likely to disrupt protein 
structure. The patient, however, had a point mutation that resulted in a proline 
substitution which may have altered the secondary structure of the protein more than 
alanine substitution we used. Because we did not observe any negative impact resulting 
from an alanine substitution at T71, it is possible that the lymphocytopenia observed in 
the human patient was due to altered protein conformation. 
Our findings provide valuable insight into the importance of the Artemis C-
terminal domain. Together, these results indicate that the C-terminus contains regions 
that are important for DNA end-processing and also for preventing aberrant 
recombination events likely by stabilizing the post-cleavage complex. Our results also 
suggest that there may be regions in the N-terminus that are specific for the Artemis 
nuclease and are important for promoting V(D)J recombination. These findings provide 
insight into the requirements of end-processing and the prevention of aberrant V(D)J 
recombination. 
Materials and methods 
Protein purification 
Artemis constructs were cloned into pCDNA6-myc-HIS plasmid. Plasmid 
constructs were transfected into 293T cells using Lipofectamine 2000 (Invitrogen) 
transfection reagent. A partial purification of Artemis protein was then performed as 
described previously [1]. Briefly, cell lysate was then harvested after 48 hours by 
sonication and centrifugation. Artemis protein was then purified using Ni-NTA beads 
followed by protein G Sepharose beads(GE Healthcare). Artemis protein bound to 
protein G beads were resuspended in Buffer G (25 mM HEPES pH 7.9, 10 mM MgCl2, 
10% glycerol, and 2 mM DTT). Artemis protein levels were then normalized by Western 
blotting. DNA-PKcs was purified from HeLa cells using a previously described protocol 
[28] 
Endonuclease assay 
Endonuclease assays were performed as previously described [5]. DNA hairpin 
substrates and overhang substrates were 5’ end labeled using T4 polynucleotide kinase 
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(NEB) and 32P γ-ATP (Perkin Elmer). End-labeled oligo (36-nt for overhang, 40-nt for 
hairpin) was then annealed to a complementary oligo (21-nt for overhang, hairpin 
anneals to self) by heating followed by slow cooling. Annealed substrates were purified 
using a 17% non-denaturing polyacrylamide gel. 
Nuclease reactions with the hairpin substrate were performed using 0.125 pmol 
of labeled substrate in 25 mM Tris pH 8.0, 10 mM MgCl2/10 mM MnCl2, 0.05 μg/μl 
BSA,0.25 mM ATP, and 10 ul of purified protein in Buffer G in a total volume of 20 ul. 
Hairpin reactions were incubated for 2 hours at 37 C. Nuclease reactions using 
overhang substrate were performed in the same buffer conditions except 0.250 pmol of 
labeled substrate was used instead. Overhang substrate reactions were performed at 
37 C for 1 hour. Reactions were stopped with 1 ul of 0.5M EDTA and 10 ul of deionized 
formamide. Reactions were then visualized by separation in 17% denaturing urea 
acrylamide gel and autoradiography. 
Transient V(D)J recombination assay 
SV40 transformed MEFs were transfected using Superfect transfection reagent 
(Qiagen). The plasmids transfected were the inversional recombination plasmid 
substrate pJH299, full length murine RAG1 and RAG2 expression constructs, and 
plasmid constructs expressing a nuclease where indicated. Cells were harvested after 
48 hours and plasmids were extracted using alkaline lysis and phenol/chloroform 
extraction. Plasmids were transformed into MC1061 E. coli and plated on ampicillin (250 
ug/ml) plates or ampicillin and chloramphenicol (10ug/ml) double selection plates. 
Recombination frequency was determined using the ratio of colonies on double 
selection plates over single selection plates. Colonies were picked from double 
selection plates and plasmids extracted using Qiagen Mini-prep kit. Plasmids were 
sequenced to analyze coding and hybrid joints. 
Co-immunoprecipitation of the MRN complex 
MEFs were grown to confluency, harvested, and lysed by sonication in 25 mM 
HEPES pH 7.4, 150 mM KCl, 10 mM MgCl2, 10% glycerol, 2 mM DTT and protease 
inhibitors (Roche). 6 mg of protein lysate was incubated with protein G Sepharose 
beads (GE Healthcare) and α-MRE11 antibody (4.5 ug, Cell Signaling) overnight at 4 C. 
Beads were then washed in lysis buffer followed by washes in 300 mM KCl lysis buffer. 
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Immunoprecipitates were analyzed by Western blotting using α-MRE11 (Cell Signaling), 
α-NBS1 (Novus Biologicals), and α-RAD50 (Bethyl Laboratories). 
Retroviral transduction 
Artemis cDNA constructs were cloned into an IRES-dsRED2 retroviral vector 
pMIRA.  pCL-Eco was used as the retroviral packaging plasmid [29]. Retrovirus was 
generated in HEK293T cells using calcium chloride/HEPES transfection. Viral 
supernatants were collected at 72 and 96 hours post transfection and concentrated 
using Retro-X Retroviral Concentrator (Clontech). Spinfection of Artemis-/- v-abl pre-B 
cells (clone c.30) was performed for 90 minutes. Pre-B cell clones expressing dsRED2 
were selected by FACS single cell sorting. 
Cell culture for pre-B cell system 
Artemis-/- v-abl pre-B cells were described previously [11, 17]. These cells were 
grown in Dulbecco’s modified Eagle medium supplemented with 10% fetal bovine 
serum, HEPES, non-essential amino acids, glutamine, penicillin/streptomycin, and β-
mercaptoethanol. G1 arrest was induced by treating cells with 3uM STI571 (Novartis) in 
DMSO. ATM inhibition was performed using by treating cells with 15 uM KU-55933 in 
DMSO 1 hour prior to treatment of STI571.  
Quantitative PCR 
RNA extraction was performed using RNeasy Mini Kit (Qiagen). RNA was 
reverse transcribed using M-MLV-reverse transcriptase (Invitrogen). Quantitative PCR 
was using SYBR Green Reagent (Invitrogen). 
Genomic Southern blot 
Genomic DNA was extracted from v-abl pre-B cells after indicated treatments. 40 ug of 
genomic DNA was digested overnight either with EcoRV-HF (NEB) or double digested 
with EcoRV-HF and NcoI-HF (NEB). Digestion reaction was concentrated by ethanol 
precipitation and resuspended in 30 ul TE. Electrophoresis was performed on digested 
DNA at 30 V overnight in 0.8% agarose. DNA was then transferred to Zetaprobe 
membrane (BioRad) and analyzed by Southern blot. C4B probe which was previously 
described [17] was used to detect digest fragments. 
Nested PCR 
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 Transrearrangements between the pMX-INV recombination substrate and IgLκ 
locus were detected using nested PCR and primers flanking Vκ6-23 and the IRES 
sequence of pMX-INV. 100 ng of genomic DNA from v-abl pre-B cells were used as a 
template with primers JMS528 and JMS579. The first round program was as follows: 25 
cycles of 94 C, 60 C, and 72 C at 30 seconds each stage. PCR products were purified 
using Qiagen PCR Purification Kit. The second round utilized the primers pB and pκ6d 
and the same PCR program as round one. Products were run on a 1.5% agarose gel 
and transferred to Zetaprobe. pD primer was used as a probe to detect products.  
Artemis N-terminus structural modeling 
Artemis N-terminus model was constructed using SWISS-MODEL program 
(swissmodel.expasy.org). This program used the unpublished crystal structure of the 
SNM1B conserved domain as a template for modeling [30]. 
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Figures 
 
Figure 2. 1 Artemis C-terminal truncation mutants.  Six mutants were created and expressed 
from pCDNA6-myc-HIS vector. The Artemis C-terminus has several SQ sites that can be 
phosphorylated by either the ATM or DNA-PKcs kinase. The C-terminus also has domains that 
are known to interact with either DNA-PKcs (orange) or LIG4 (blue). 
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Figure 2. 2 Regulation of endonucleolytic activity. (A) c-myc-6xHIS-tagged Artemis 
constructs were expressed in 293T cells and purified from DNA-PKcs. Protein normalization and 
purification from DNA-PKcs was confirmed by Western blot. Whole cell lysate (WCL) was used 
as a DNA-PKcs positive control. (B) Partially purified Artemis protein was incubated with a 5’ 32P 
end-labeled DNA hairpin substrate with and without purified DNA-PKcs protein. Reactions were 
then run on a 17% denaturing polyacrylamide gel and gel was exposed to X-ray film.   
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Figure 2. 3 Inversional plasmid recombination substrate pJH299. The pJH299 plasmid 
substrate has two RSSs which are represented by the triangles. The intervening sequence 
contains within it a bacterial transcriptional stop sequence. Recombination of the plasmid can 
generate either an inversional event or a deletional event resulting from the loss of the 
intervening sequence. Either recombination events will inactivate the stop sequence resulting in 
bacterial resistance to both ampicillin and chloramphenicol. Amp=ampicillin resistance gene, 
CAT=chloramphenicol acetyltransferase gene. 
 
 
 
  
56 
 
 
0
.0
0
0
.0
5
0
.1
0
0
.1
5
0
.2
0
0
.2
5
Ar te m is -P 7 0
Ar te m is -n u ll
W ild typ e
A b s o lu te  re c o m b in a tio n  fre q u e n c y   (% )
 
Figure 2. 4 Recombination frequency in Artemis-/- and Artemis-P70 backgrounds. 
Recombination frequency of inversional plasmid substrate in MEFs derived from Artemis-/- and 
Artemis-P70 mice were dramatically reduced when compared to recombination frequency in 
wildtype MEFs. MEFs were transformed with the pJH299 inversional recombination substrate 
and plasmids expressing the Rag proteins. Plasmid substrate was harvested 48 hours after 
transfection and analyzed. 
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Figure 2. 5 Aberrant events in Artemis-/- and Artemis-P70 backgrounds. Loss of the 
Artemis or the Artemis C-terminus resulted in increased aberrant joining events. Plasmid –
based V(D)J recombination assay was performed using wildtype, Artemis-P70, and  Artemis-
null MEFs. Recombined plasmid was transformed into bacteria and chloramphenicol and 
ampicillin resistant bacterial colonies were isolated, plasmids were extracted, and sequenced. 
Plasmid sequences were analyzed and recombination events were categorized as either 
inversional or deletional/aberrant. Sample size for WT = 45, Artemis-P70 = 27, Artemis-/- = 33. 
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Figure 2. 6 Signal joints, coding joints, and hybrid joints from wildtype MEFs Recombined 
pJH299 joint sequences showing nucleotide deletions (), N-nucleotide additions (N), and 
palindromic-nucleotide additions (P). Microhomologies (MH) are labeled in red.  
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0 CACAGTGCTACAGAC 
 
TCGATGAGAGGATCC 0 
   
0 GTCGACCTGCAGCCC 0 1 
 AGTACTACCACTGTG 0 
  
1 ACAGTGCTACAGAC 
 
TCGATGAGAGGATCC 0 G 
  
8 GCAGCCC 0 1 
 AGTACTACCACTGTG 0 
  
1 ACAGTGCTACAGAC 
 
  23 
   
13 CC 1 1 
 AGTACTACCACTGTG 0 
  
0 CACAGTGCTACAGAC 
 
TCGATGAGAG 5 
   
3 GACCTGCAGCCC 2 1 
 
                
10 Total 
 
RSS23 
 
Hybrid joint 
  
Coding end 
 
 
 AGTACTACCACTGTG  Insertion P  GTCGACCTGCAGCCC MH Clones 
 AGTACTACCACTGTG 0 
  
3 GACCTGCAGCCC 0 2 
 AGTACTACCACTGTG 0 
  
10 AGCCC 0 2 
 AGTACTACCACTGTG 0 
  
5 CCTGCAGCCC 0 2 
 AGTACTACCACTGTG 0 
 
AC 0 GTCGACCTGCAGCCC 0 1 
 AGTACTACCACTGTG 0 G 
 
3 GACCTGCAGCCC 0 1 
 AGTACTACCACTGTG 0 
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RAG2 gene 1 1 
 AGTACTACC 6 
 
AC 0 GTCGACCTGCAGCCC 2 1 
   24 
  
16 AG 2 1 
 AGTACTACCAC 4 
  
80   0 1 
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Figure 2. 7 Signal joints, coding joints, and hybrid joints Artemis-P70 MEFs  Recombined 
pJH299 joint sequences showing nucleotide deletions (), N-nucleotide additions (N), and 
palindromic-nucleotide additions (P). Microhomologies (MH) are labeled in red. 
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Figure 2. 8 Signal joints, coding joints, and hybrid joints from Artemis-/- MEFs. 
Recombined pJH299 joint sequences showing nucleotide deletions (), N-nucleotide additions 
(N), and palindromic-nucleotide additions (P). Microhomologies (MH) are labeled in red.  
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Figure 2. 9 ATM activity and MRN stability in Artemis-P70 backgrounds. (A-B) Wildtype, 
Artemis-null, Artemis-P70, and ATM-null MEFs were irradiated (10 Gy) and harvested after 1 
hour. Phosphorylated ATM was visualized using Western blot and phospho-ATM antibody. 
Antibodies against phosphorylated ATM substrates gH2AX and Kap1 were used to assess ATM 
activity on downstream targets. Alpha tubulin was used as a normalization control. (C) Mre11 
immunoprecipitation was performed on cell lysates from wildtype and Artemis-P70 MEFs. Co-
immunoprecipitation of protein complex partners were detected with antibodies against Nbs1 
and Rad50. WCL = whole cell lysate, (-) = no antibody, (+) = with Mre11 antibody.  
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Figure 2. 10 pMX-INV intrachromosomal recombination substrate. pMX-INV was integrated 
into the chromosome of  Artemis-null murine pre-B cells using retroviral transduction. To ensure 
all cells contain the substrate, cells were sorted for expression of human CD4. Treatment of cell 
lines with STI571 induces Rag expression and recombination. Recombination events can be 
analyzed using genomic Southern blot and PCR Southern blot. Coding joins and hybrid joins 
are analyzed by digesting genomic DNA with EcoRV and NcoI. Hybrid joining and accumulation 
of coding ends can be determined with EcoRV single digest. Transrearrangements are analyzed 
using PCR with indicated primers. 
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Figure 2. 11 RNA expression level of Artemis constructs in pre-B cell lines. (A) Artemis 
mRNA analysis of vector-only clone (pMIRA A1), 3 wildtype Artemis expressing clones, 3 
MβL/βCASP expressing clones, and 3 D451X expressing clones  by RT-PCR. Housekeeping 
gene GAPDH used as a normalization control. (B) Artemis mRNA analysis of construct-
expressing clones using quantitative PCR.  
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Figure 2. 12 Loss of Artemis C-terminus increases aberrant rearrangement products. Pre 
B cell lines were treated with STI571 or both STI571 and ATM-inhibitor KU55933 (ATMi). Cells 
were harvested at 96 hours and genomic DNA isolated. (A) Genomic DNA was digested with 
either EcoRV or (B) EcoRV and NcoI. Unrecombined substrate (UR), coding joins (CJ), Hybrid 
joins (HJ), and coding ends (CE) were visualized using genomic Southern blot.  
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Figure 2. 13 Loss of the Artemis C-terminus results in Increased transrearrangements. 
Pre-B cell clones were treated with either ATM inhibitor KU55933 (ATMi), STI571, or both 
drugs. Cells were harvested at 96 hours post STI571 treatment and genomic DNA extracted. 
Nested PCR was used to amplify transrearrangements (refer to Figure 2.9). Amplification of 
ATM was used for normalization.  
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Table 2. 1 Human Artemis N-terminal missense point mutations. 
 
  
Mutation Second allele Lymphocytes IR sensitivity (fibroblasts) Study 
H228N  Deletion of exon 1-4  Absent  Sensitive  Pannicke et al. 2010 
I16T  S119X  Absent  Sensitive  Musio et al. 2005  
T71P  Deletion of exon 1-3  Lymphopenia  Normal  Lee et al. 2013  
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Figure 2. 14 Putative N-terminal regulatory domains. Several sites have been reported in the 
literature to be important for Artemis activity. These sites are labeled above the Artemis protein 
diagram. This study focused on sites that may play a role in regulating the nuclease but are 
unexplored or not well studied (labeled below the protein diagram)  
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Figure 2. 15 Locations of putative regulatory domains on predicted structure. Artemis N-
terminal domain structure prediction was generated by SWISS-MODEL and based on the 
crystallized structure of the Snm1B conserved domain. The Artemis N-terminus consists of two 
domains, the metallo-β-lactamase domain and the β-CASP domain. Here, the metallo-β-
lactamase domain is depicted below the β-CASP domain with two peptide linkers separating the 
two. Loops in between the two domains are predicted to be important for coordinating a metal 
ion important for catalytic function. Red regions represent stretches of Artemis protein sequence 
that was unique when aligned with Snm1B. Regions that were analyzed by this study are 
labeled.  
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Figure 2. 16 KRR>3A and LHSG>4A mutations disrupt endonucleolytic activity. c-myc-
6xHIS-tagged Artemis constructs were expressed in 293T cells and purified from DNA-PKcs. 
Protein normalization and purification from DNA-PKcs was confirmed by Western blot. Artemis 
protein was incubated with a 5’ 32P end-labeled DNA overhang (left) and hairpin (right) substrate 
in the presence of manganese. Reactions were then run on a 17% denaturing polyacrylamide 
gel and gel was exposed to X-ray film.   
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Figure 2. 17 Nuclease overexpression in the transient V(D)J assay (A) Plasmid expression 
of nucleases in 293T cells. (B) Nucleases were expressed from plasmid in Artemis-null MEFs 
along with inversional recombination plasmid substrate pJH299 and plasmids expressing the 
Rag proteins. Artemis truncation mutant and T71A mutant rescues V(D)J recombination defect 
but overexpression of other nucleases do not facilitate recombination.  
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Figure 2. 18 
Inversions and deletional joins recovered from transient V(D)J assay. Plasmid –based 
V(D)J recombination assay was performed using Artemis-null MEFs transiently expressing 
either wildtype Artemis, MβL/βCASP Artemis, MβL/βCASP-T71A, or full length Artemis-T71A 
mutant. Chloramphenicol and ampicillin resistant bacteria colonies were isolated, plasmid was 
extracted and sequenced. 
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Figure 2. 19 Signal, coding, and hybrid joints from wildtype MEFs. Recombined pJH299 
joint sequences showing nucleotide deletions (), N-nucleotide additions (N), and palindromic-
nucleotide additions (P). Microhomologies (MH) are labeled in red.  
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Figure 2. 20 Signal, coding, and hybrid joints from MEFs expressing MβL/βCASP. 
Recombined pJH299 joint sequences showing nucleotide deletions (), N-nucleotide additions 
(N), and palindromic-nucleotide additions (P). Microhomologies (MH) are labeled in red.  
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2 CGACCTGCAGCCC 0 1 
 AGTACTACCACTGTG 0 
 
0 CACAGTGCTACAGAC 
 
TCGATGAGAGGATC 1 
   
0 GTCGACCTGCAGCCC 0 2 
 AGTACTACCACTGTG 0 
 
0 CACAGTGCTACAGAC 
 
TCGATGAGAGGATCC 0 
   
3 GACCTGCAGCCC 0 1 
 AGTACTACCACTGTG 0 
 
0 CACAGTGCTACAGAC 
 
TCGATGAGAGGATCC 0 
   
1 TCGACCTGCAGCCC 0 1 
 AGTACTACCACTGTG 0 
 
0 CACAGTGCTACAGAC 
 
TCGATGAGAG 5 
   
3 GACCTGCAGCCC 2 1 
 AGTACTACCACTGTG 0 
 
0 CACAGTGCTACAGAC 
 
TCGATGAGAGGATCC 0 GG 
  
6 CTGCAGCCC 0 1 
 AGTACTACCACTGTG 0 
 
0 CACAGTGCTACAGAC 
 
TCGATGAGAGGA 3 
  
C 0 GTCGACCTGCAGCCC 0 2 
 AGTACTACCACTGTG 0 
 
0 CACAGTGCTACAGAC 
 
TCGATGAGAGGATCC 0 
   
10 AGCCC 0 1 
 AGTACTACCACTGTG 0 
 
0 CACAGTGCTACAGAC 
 
TCGATGAGAGG 4 
   
0 GTCGACCTGCAGCCC 0 1 
 AGTACTACCACTGTG 0 
 
0 CACAGTGCTACAGAC 
 
TCGATGAGAGG 4 
  
C 0 GTCGACCTGCAGCCC 0 1 
 AGTACTACCACTGTG 0 
 
0 CACAGTGCTACAGAC 
 
  23 
   
1 TCGACCTGCAGCCC 2 1 
 AGTACTACCACTGTG 0 
 
0 CACAGTGCTACAGAC 
 
TCGATGAGAGG 4 
   
8 GCAGCCC 0 1 
 AGTACTACCACTGTG 0 
 
0 CACAGTGCTACAGAC 
 
TCGATGAGA 6 
   
3 GACCTGCAGCCC 1 1 
 AGTACTACCACTGTG 0 
 
0 CACAGTGCTACAGAC 
 
TCGATGAGAGGATCC 0 
   
0 GTCGACCTGCAGCCC 0 1 
 AGTACTACCACTGTG 0 
 
0 CACAGTGCTACAGAC 
 
TCGATGAGAGGAT 2 
   
8 GCAGCCC 0 1 
 
              
23 Total 
  
RSS23 
 
Coding joint 
  
CJ Right 
   AGTACTACCACTGTG  N P  GTCGACCTGCAGCCC MH Clones 
 AGTACTACCACTGTG 0 
 
AC 0 GTCGACCTGCAGCCC 0 3 
 AGTACTACCACTGT 1 
  
3 GACCTGCAGCCC 1 2 
 AGTACTACCACTGTG 0 
  
5 CCTGCAGCCC 0 2 
 AGTACTACCACTG 2 
 
AC 0 GTCGACCTGCAGCCC 0 2 
 AGTA 11 
  
67 CT 2 1 
 AGTACTACCACTGTG 0 
  
2 CGACCTGCAGCCC 0 1 
   3 
  
24 GT 2 1 
   21 
  
9 CAGCCC 0 1 
 AG 13 A AC 0 GTCGACCTGCAGCCC 0 1 
 AGTACTACCACTGTG 0 
  
1 TCGACCTGCAGCCC 1 1 
 AGTACTACCACTGTG 0 
  
4 ACCTGCAGCCC 1 1 
 AGTACTACCACTGT 1 
  
2 CGACCTGCAGCCC 2 1 
 AGTACTACCACTGTG 0 
  
6 CTGCAGCCC 0 1 
 
       
18 Total 
 
Figure 2. 21 Signal, coding, and hybrid joints from MEFs expressing MβL/βC-T71A. 
Recombined pJH299 joint sequences showing nucleotide deletions (Δ), N-nucleotide additions 
(N), and palindromic-nucleotide additions (P). Microhomologies (MH) are labeled in red.  
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RSS23 
 
Signal joint 
 
RSS12 
 
Coding end 
  
Coding joint 
  
Coding end 
   AGTACTACCACTGTG  N  CACAGTGCTACAGAC   TCGATGAGAGGATCC  P N P  GTCGACCTGCAGCCC MH Clones 
 AGTACTACCACTGTG 0 
 
0 CACAGTGCTACAGAC 
 
TCGATGAGAGGAT 2 
   
5 CCTGCAGCCC 2 3 
 AGTACTACCACTGTG 0 
 
0 CACAGTGCTACAGAC 
 
TCGATGAGAGGATC 1 
   
2 CGACCTGCAGCCC 1 3 
 AGTACTACCACTGTG 0 
 
0 CACAGTGCTACAGAC 
 
TCGATGAGAGGA 3 
   
1 TCGACCTGCAGCCC 2 3 
 AGTACTACCACTGTG 0 
 
0 CACAGTGCTACAGAC 
 
TCGATGAGAGGATC 1 
   
0 GTCGACCTGCAGCCC 0 2 
 AGTACTACCACTGTG 0 
 
0 CACAGTGCTACAGAC 
 
TCGATGAGAGGA 3 
   
7 TGCAGCCC 1 2 
 AGTACTACCACTGTG 0 
 
0 CACAGTGCTACAGAC 
 
TCGATGAGAGGATC 1 
   
5 CCTGCAGCCC 1 2 
 AGTACTACCACTGTG 0 
 
0 CACAGTGCTACAGAC 
 
TCGATGAGAGGATCC 0 
   
0 GTCGACCTGCAGCCC 0 2 
 AGTACTACCACTGTG 0 
 
0 CACAGTGCTACAGAC 
 
TCGATGAGAGGAT 2 
   
6 CTGCAGCCC 1 2 
 AGTACTACCACTGTG 0 
 
0 CACAGTGCTACAGAC 
 
TCGATGAGAGGATC 1 
   
4 ACCTGCAGCCC 0 1 
 AGTACTACCACTGTG 0 
 
0 CACAGTGCTACAGAC 
 
TCGATGAGA 6 
   
6 CTGCAGCCC 0 1 
 AGTACTACCACTGTG 0 
 
0 CACAGTGCTACAGAC 
 
TCGATGAGAGGA 3 
  
AC 0 GTCGACCTGCAGCCC 0 1 
 AGTACTACCACTGTG 0 
 
0 CACAGTGCTACAGAC 
 
TCGATGAGAGGATCC 0 
   
2 CGACCTGCAGCCC 0 1 
 AGTACTACCACTG 2 
 
0 CACAGTGCTACAGAC 
 
TCGATGAGAGGA 3 
  
C 0 GTCGACCTGCAGCCC 0 1 
 AGTACTACCACTGTG 0 
 
0 CACAGTGCTACAGAC 
 
TCGATGAGAGGATCC 0 G 
  
0 GTCGACCTGCAGCCC 0 1 
 AGTACTACCACTGTG 0 
 
0 CACAGTGCTACAGAC 
 
TCGATGAGAGGATC 1 
   
8 GCAGCCC 0 1 
 AGTACTACCACTGTG 0 
 
0 CACAGTGCTACAGAC 
 
TCGATGAGAGGATCC 0 G 
  
4 ACCTGCAGCCC 1 1 
 AGTACTACCACTGTG 0 
 
0 CACAGTGCTACAGAC 
 
TCGATGAGAGGAT 2 
   
9 CAGCCC 1 1 
 AGTACTACCACTGTG 0 
 
0 CACAGTGCTACAGAC 
 
TCGATGAGAGG 4 
   
8 GCAGCCC 0 1 
 AGTACTACCACTGTG 0 
 
0 CACAGTGCTACAGAC 
 
TCGATGAGAGG 4 
   
0 GTCGACCTGCAGCCC 0 1 
 AGTACTACCACTGTG 0 
 
0 CACAGTGCTACAGAC 
 
TCGATGAGAGGATCC 0 
   
8 GCAGCCC 0 1 
 AGTACTACCACTGT 1 
 
0 CACAGTGCTACAGAC 
 
TCGATGAGAGG 4 
 
T 
 
7 TGCAGCCC 0 1 
 AGTACTACCACTGTG 0 
 
0 CACAGTGCTACAGAC 
 
TCGATGAGAGGATCC 0 GG 
  
3 GACCTGCAGCCC 0 1 
 AGTACTACCACTGTG 0 
 
0 CACAGTGCTACAGAC 
 
TCGATGA 8 
   
3 GACCTGCAGCCC 2 1 
 AGTACTACCACTGTG 0 
 
0 CACAGTGCTACAGAC 
 
TCG 12 
   
6 CTGCAGCCC 0 1 
 AGTACTACCACTGTG 0 
 
0 CACAGTGCTACAGAC 
 
TCGATGAGAGGAT 2 
   
7 TGCAGCCC 0 1 
 
              
36 Total 
 
RSS23 
 
Hybrid joint 
  
Coding end 
   AGTACTACCACTGTG  N P  GTCGACCTGCAGCCC MH Clones 
 AGTACTACCACTGTG 0 
  
2 CGACCTGCAGCCC 0 2 
 AGTACTACCACTGTG 0 
  
4 ACCTGCAGCCC 1 2 
 AGTACTACCACTGTG 0 
 
AC 0 GTCGACCTGCAGCCC 0 1 
 AGTACTACCACTGTG 0 
  
10 AGCCC 0 1 
 AGTACTACCACTGTG 0 
  
122 
 
3 1 
 
 
57 
  
56 AT 2 1 
 AGTACTACCACTGTG 0 
  
8 GCAGCCC 0 1 
 AGTACTACCACTGTG 0 
  
5 CCTGCAGCCC 0 1 
 AGTACTACCACT 3 
  
3 GACCTGCAGCCC 1 1 
 
       
11 Total 
 
Figure 2. 22 Signal, coding, and hybrid joints from MEFs expressing full length T71A. 
Recombined pJH299 joint sequences showing nucleotide deletions (), N-nucleotide additions 
(N), and palindromic-nucleotide additions (P). Microhomologies (MH) are labeled in red.  
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Chapter 3 
Cooperation between the Artemis C-terminus and the ATM kinase in lymphocyte 
development and immune regulation 
Abstract 
Human patients with mutations in the ARTEMIS gene exhibit severe combined 
immunodeficiency and radiosensitivity (RS-SCID) with an absence of B and T 
lymphocytes. Patients with hypomorphic mutations involving the Artemis C-terminus 
have been described and these patients exhibit partial loss of B and T lymphocytes but 
with a predisposition of lymphoid malignancies. Our lab has previously generated a 
mouse model for human patients with hypomorphic Artemis mutant alleles which we call 
Artemis-P70. Artemis-P70 mice have an early stop codon that truncates the majority of 
the Artemis C-terminus. Lymphocytes from these mice produce aberrant V(D)J 
rearrangement products and in addition, when these mice are crossed into a p53-/- 
background, all mice succumb to lymphomas that harbor clonal translocations. 
To address the genetic interactions between the Artemis C-terminus and the 
ataxia telangiectasia mutated (ATM) kinase, I crossed our Artemis-P70 mice into mice 
from an ATM-/- background. Despite the propensity of ATM-/- mice and Artemis-P70 
p53-/- mice for tumorigenesis, the double mutant mice do not develop any observable 
tumors. As a result, these mice survived significantly longer than ATM-/- and Artemis-
P70 p53-/- mice. Loss of both the Artemis C-terminus and ATM resulted in a lymphocyte 
deficiency that was more severe than loss of either factor alone. Hematopoietic stem 
cell population depletion was not found to be the source of this deficiency. Surprisingly, 
these mice exhibited thickened and inflamed colons with infiltrating T cells and 
neutrophils. Together, these results indicate that the ATM kinase and Artemis C-
terminus cooperatively facilitate lymphocyte development. The severe, although 
incomplete, depletion of lymphocytes may give rise to mice that are uniquely 
susceptible to chronic inflammation. 
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Introduction 
The ARTEMIS gene was first discovered in a population of Athabascan speaking 
American Indians with radiosensitive severe combined immunodeficiency (SCID). 
These patients had an absence of B and T lymphocytes with a normal population of NK 
cells. In addition to immunodeficiency, cells from these patients exhibit radiosensitivity 
[1]. The Artemis protein was soon found to play a critical role in the development of B 
and T cells and in general double strand break (DSB) repair [2]. 
The antigen receptors of B and T cells (BCRs and TCRs, respectively) can 
recognize a large variety of substrates including foreign pathogens and toxins. The 
process required to generate antigen receptors with this level of diversity is called V(D)J 
recombination. During this gene rearrangement event, the Rag endonuclease 
comprised of the RAG1 and RAG2 proteins introduce DSBs at recombination signal 
sequences (RSS) adjacent to the gene segments that code for the B and T cell 
receptors. Rag DNA cleavage generates two types of DNA ends, a blunt “signal” end 
adjacent to the RSS, and a covalently sealed hairpin “coding” end adjacent to the gene 
segment which codes for the antigen receptor. In order for the gene segments to be 
joined, the hairpin coding end must be opened. The opening of these hairpin coding 
ends was found to be dependent on the DNA-dependent protein kinase, catalytic 
subunit (DNA-PKcs) and the Artemis nuclease. Loss of Artemis results in the 
accumulation of unopened coding ends and B and T cell development is arrested [1, 2]. 
Artemis also takes part in the general DSB repair process nonhomologous end 
joining (NHEJ). There are six other NHEJ factors: KU70, KU80, DNA-PKcs, XRCC4, 
XLF, and the ligase LIG4. KU70 and KU80 first recognize and bind to the DSB. DNA-
PKcs and Artemis is recruited and some of these ends are processed by the Artemis 
nuclease. It is estimated that about 10% of breaks induced by ionizing radiation requires 
Artemis to process DNA ends prior to rejoining [3]. The break is then joined by the 
ligation complex which includes XRCC4, XLF, and LIG4.  
The majority of human Artemis mutations occur in the conserved catalytic N-
terminal domain resulting in arrested V(D)J recombination and the loss of B and T cells 
[4]. This N-terminus (a.a. 1-385) consists of a metallo-β-lactamase and β-CASP domain 
which together forms the active site of the nuclease [1, 5, 6]. Human patient mutations 
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were soon discovered in the C-terminal domain (a.a. 396-692) [7]. Patients that had 
nonsense mutations in this domain resulting in early stop codons had a milder B and T 
cell defect and as a result these mutations are referred to as hypomorphic.  Some 
hypomorphic Artemis mutant patients died of infection and interestingly, some others 
succumbed to Epstein-Barr virus (EBV) associated lymphoma. These tumors were of 
clonal origin and had chromosomal alterations indicating genomic instability. The tumor 
characteristics suggest that the Artemis C-terminus may be important for not only for 
V(D)J recombination but to prevent tumorigenesis.  
The Artemis C-terminus has been shown to be important for interaction with 
DNA-PKcs at L401 R402 [8] and LIG4 at W489 and these interactions are important for 
efficient V(D)J recombination [9]. This domain has also been shown to be important for 
efficient endonucleolytic activity [10, 11] and has multiple SQ phosphorylation sites that 
can act as a substrate for either DNA-PKcs or the ataxia-telangiectasia mutated (ATM) 
kinase [8, 12-16]. However, the functional significance of Artemis phosphorylation has 
yet to be elucidated.  
To further investigate the functional role of the Artemis C-terminus in vivo, we 
have generated a mouse model of one of the human hypomorphic Artemis mutant 
alleles. Human patients with this allele have a 7-nucleotide deletion at aspartic acid 451 
which results in a frameshift and an early stop codon (D451fsX10). Our mouse model, 
which we refer to as P70, has an early stop codon introduced to aspartic acid 449 and 
like the human patient allele, results in the loss of most of the C-terminal domain. 
Artemis-P70 mice have reduced B and T cell populations and when crossed into p53-
deficient backgrounds, all mice succumb to B and T cell lymphoma. We found that 
Artemis-P70 thymocytes have increased coding end accumulation and these coding 
ends can go on to engage in aberrant transrearrangements. [11, 17] 
The ATM kinase plays important roles in cell cycle arrest and general DSB repair 
in response to radiation [18]. Although ATM does not seem to play a direct role in V(D)J 
recombination, loss of ATM does impact lymphocyte development. ATM-/- mice have a 
mild B and T lymphocyte deficiency and succumb to thymic lymphoma [19]. ATM-
deficient lymphocytes also accumulate coding ends and harbor aberrant 
rearrangements [20, 21]. These findings have led to the hypothesis that ATM and its 
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kinase activity may be important for stabilizing the post-cleavage complex (PCC), a 
complex of proteins thought to be important for the synapsis of Rag-generated DNA 
ends.  
There have been some reports that suggest that the ATM kinase and Artemis 
may operate in the same pathway during general DSB repair. ATM-deficient and 
Artemis-deficient fibroblasts were found to display identical levels of sensitivity to 
ionizing radiation and treatment of Artemis-deficient fibroblasts with the ATM inhibitor 
KU-55933 did not increase sensitivity to ionizing radiation [3]. Furthermore, one report 
found the Artemis plays a role in homologous recombination and that its function here 
was in the same pathway as ATM [22]. As mentioned above, ATM can phosphorylate 
Artemis at its C-terminus in response to ionizing radiation although the function of this 
event is unclear [3, 16]. Despite some evidence that ATM and Artemis could function in 
the same pathway during DSB repair, it is unclear whether this is the case during V(D)J 
recombination.  
In order to address the relationship between the Artemis C-terminus and the 
ATM kinase in vivo, we crossed our Artemis-P70 mouse to an ATM-/- background. 
Surprisingly, we found that this cross rescued the lymphoma phenotype observed in 
both single mutants. These mice also lived significantly longer than ATM-/- mice and 
Artemis-P70 p53-/- mice. Artemis-P70 ATM-/- mice exhibited severely reduced 
lymphocyte numbers when compared to single mutant mice. Despite the lack of tumors, 
these mice become moribund earlier than Artemis-P70 littermates and unexpectedly, 
we find that these mice exhibited thickened and inflamed colons. Together, these 
results indicate that the loss of both factors, ATM and the Artemis C-terminus, has an 
additive negative impact on lymphocyte development. However, the severely 
compromised immunity of these mice may result in a disregulated response in the colon 
resulting in chronic inflammation. 
Results 
Survival of Artemis-P70 ATM-/- double mutant mice 
We have previously noted similarities between the phenotypes observed in the 
Artemis-P70 mice and ATM deficient mice. Both mutant mice have lymphocyte 
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deficiencies and are prone to lymphoma. ATM deficient mice succumb to thymic 
lymphoma between 2 and 4 months of age [19, 23].  A proportion of Artemis-P70 mice 
succumb to T cell lymphoma but when this mutation was crossed into a p53-/- 
background, all mice died of either thymic lymphoma or pro-B lymphoma [17]. Both 
genotypes display increased aberrant V(D)J rearrangements [11, 17, 19, 20, 23]. These 
similarities has led us to speculate that the Artemis C-terminus and the ATM kinase may 
function epistatically in preventing aberrant V(D)J rearrangements which then result in 
lymphocyte deficiencies and lymphoma.  
In order to determine the impact of the loss of ATM in Artemis-P70 mice on 
survival and tumorigenesis, Artemis-P70 ATM-/- double mutant mice were generated 
through mouse breedings. Our lab had in the past generated Artemis-P70 p53-/- mice 
as well as the Artemis-/- p53-/- mice and found that these mice succumb to lymphoma 
with a median survival between 11 and 13 weeks [17]. Strikingly, unlike the ATM-/- 
mice, the Artemis-P70 p53-/- double mutants, and the Artemis-/- p53-/- mice, no tumors 
were found in the Artemis-P70 ATM-/- double mutant mice at time of death. The lack of 
tumors extended the lifespan of Artemis-P70 ATM-/- double mutant mice when 
compared to ATM-/- mice (median survival of 31 weeks for double mutant mice 
compared to median survival of 21.85 weeks for ATM-/- mice, P=0.02, two-tailed log 
rank test). Although the double mutant mice were rescued of lymphoma, these mice 
were small, thin, suffered from diarrhea, and experienced a failure to thrive. (Figure 3.1) 
In contrast, Artemis-/- ATM-/- mice have been reported to live up to 36 months 
without tumors [24]. These mice are reported to appear healthy but smaller. Similarly, 
my preliminary data (n=6) has shown that these mice do not exhibit lymphoid tumors 
and seem to survive longer than Artemis-P70 ATM-/- mice with a median survival of 
52.15 weeks.   
Lymphocyte analysis of Artemis-P70 ATM-/- double mutant mice 
Both Artemis-P70 mice and ATM-/- mice have been shown to exhibit mild B and 
T lymphocyte deficiencies. I utilized the Artemis-P70 ATM-/- double mutant mice to 
explore the relationship between the Artemis C-terminus and the ATM kinase on 
lymphocyte development. To this end, mice 6-8 weeks of age were euthanized and 
lymphoid organs were collected and dissociated. Lymphocytes were stained with 
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antibodies against B and T cell surface markers and analyzed using flow cytometric 
analysis (Figure 3.2). 
Different cell surface proteins are present during different stages of lymphocyte 
development. This analysis allows us to determine how the mutant genotypes are 
affecting specific stages of lymphocyte development. Thymocytes begin rearranging the 
TCR-chain genes during the double negative stage, when neither cell surface markers 
CD4 and CD8 are detectable. These thymocytes then progress to the double positive 
stage when the TCR -chain is rearranged. Double positive thymocytes then progress 
into the single positive stage, either displaying CD4 or CD8 on the cell surface. Single 
positive cells then migrate out of the thymus and into the peripheral tissues.  
Our lab has previously found that Artemis-P70 thymocytes experience a partial 
block at the double negative stage and this resulted in fewer double positive 
thymocytes. Artemis-P70 ATM-/- double mutant mice have a more severe defect in 
double positive thymocytes when compared to either Artemis-P70 or ATM-/- mice 
(Artemis-P70 = 66%, ATM-/- = 54%, Artemis-P70 ATM-/- = 0.49%). Similarly, there 
were much fewer single positive peripheral T cells in our double mutant mice lymph 
nodes than in single mutant mice (CD4+, Artemis-P70 = 15%, ATM-/- = 23% Artemis-
P70 ATM-/- = 2.3%) (CD8+, Artemis-P70 = 12%, ATM-/- = 18%, Artemis-P70 ATM-/- = 
2.2%). However, this defect was not as severe as in Artemis-/- mice (CD4+ Artemis-/- = 
0.46%, CD8+ Artemis-/- = 0.03%). (Table 3.1) 
We also analyzed the development of B cells in Artemis-P70 ATM-/- mice. B 
lymphocytes begin development in the bone marrow where the Rag endonuclease 
initiates recombination in the pro-B cell stage (B220+ CD43+). During this stage, the 
immunoglobulin heavy-chain genes are rearranged. After successful rearrangement, the 
lymphocyte then moves into the pre-B cell stage (B220+ CD43-) where the light-chain 
genes are rearranged. Productive rearrangements results in the expression of surface 
IgM antibody and an exit out of the pre-B cell stage and into the immature B cell stage. 
These cells then undergo negative selection in the bone marrow to eliminate cells 
expressing self-reactive antibodies. Surviving cells then leave the bone marrow and 
migrate to the peripheral tissues  
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We had previously shown that Artemis-P70 B lymphocytes experience a block 
between the pro-B and pre-B cell stage resulting in low pre-B cell number and an 
accumulation of pro-B cells. Our lab had also found that Artemis-P70 mice had fewer 
IgM expressing lymphocytes than wildtype mice. I analyzing the lymphocytes of the 
Artemis-P70 ATM-/- double mutant mice and found these mice to have significantly 
fewer pro-B, pre-B, and IgM+ splenocytes than either Artemis-P70 or ATM-/- single 
mutant mice (Table 3.1). The significant reduction in pro-B cells suggests a more severe 
defect in V(D)J recombination during the very early stages of heavy-chain 
rearrangement resulting in the programmed cell death of these cells. Alternatively, this 
phenotype could suggest that Artemis-P70 ATM-/- mice have a defect in the 
maintenance of the hematopoietic stem cell (HSC) population.  
There are some reports indicating that DNA repair factors are important for the 
maintenance of HSCs [25, 26]. One report demonstrated that older ATM-/- mice had 
defective HSC function associated with oxidative stress [27]. To address whether the 
Artemis-P70 ATM-/- mice had HSC deficiencies, bone marrow from wildtype and double 
mutant mice between the ages of 5 and 24 weeks was harvested. Bone marrow cells 
were stained and analyzed using an established protocol identifying HSCs as lineage 
negative, c-kit positive, Sca-1 positive, CD48 negative, and CD150 positive [28]. We did 
not detect any significant differences in HSCs in Artemis-P70 ATM-/- mice when 
compared to wildtype at any age analyzed (Figure 3.3).   
Rearrangements in Artemis-P70 ATM-/- backgrounds result in 
transrearrangements 
Our lab had previously found that lymphocytes from Artemis-P70 mice harbored 
aberrant transrearrangements [17]. We noted the similarities between the Artemis-P70 
phenotype and what has been reported in the literature for ATM-deficiency. Thymocytes 
and splenocytes from ATM-deficient mice have also been shown to harbor aberrant 
rearrangements and as a result, we asked how the Artemis C-terminus and the ATM 
kinase could contribute to promoting proper recombination.  
I isolated thymocyte DNA from the Artemis-P70 ATM-/- double mutant mice and 
using nested PCR and Southern blot, rearrangements that occurred within the TCR 
locus were analyzed. Nested PCR Southern blot was also utilized to detect aberrant 
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rearrangements products between the TCR locus and the TCR locus, one locus on 
chromosomes 6 and the other on chromosome 13, respectively (Figure 3.4 A). As 
expected, aberrant transrearrangements were detected in both Artemis-P70 and the 
ATM-/- thymocytes but were rare in wildtype thymocytes. I found that the Artemis-P70 
ATM-/- double mutant mice also harbored transrearrangements between the two loci. 
However, nested PCR amplified fewer aberrant transrearrangements in the double 
mutant thymocytes when compared to either Artemis-P70 and ATM-/- single mutants. 
(Figure 3.4 B) 
To compare the ratio of aberrant joins to normal rearrangements, the Southern 
blot was exposed to a phosphorimager screen and band intensity was measured using 
phosphorimager software (Figure 3.4 C). I found that the ratio of aberrant joins to 
normal joins in double mutant mice was statistically no different than the ratio found in 
Artemis-P70 or ATM-/- thymocytes. This result suggests that Artemis C-terminus and 
the ATM kinase work epistatically in the prevention of aberrant rearrangements in 
developing thymocytes. However, I have found previously that inhibiting ATM kinase 
activity in Artemis-P70 protein expressing pre-B cells increased transrearrangements 
(Chapter 2, Figure 2.13). A possible explanation for this difference is that in Artemis-P70 
ATM-/- mice, many thymocytes that harbored aberrant rearrangements may have been 
eliminated from the population as a result of non-productive rearrangements and 
therefore, those events were not detected in this experiment.    
Artemis-P70 ATM-/- double mutant mice are glucose tolerant 
Our lab had previously observed that 2 of our 14 Artemis-P70 mice succumb to 
thymic lymphoma during a 12 month period [17]. As reported in the literature, nearly all 
ATM-/- succumb to thymic lymphoma [19] and our ATM-/- mice have a median survival 
of only 22 weeks. Despite the tumor phenotype of the two single mutant mice, our 
Artemis-P70 ATM-/- double mutant notably did not have any observable tumors. 
However, the absence of tumors did not extend the longevity of the double mutant mice 
to wildtype levels as they had a median survival of only 31 weeks (Figure 3.1). These 
mice were smaller at birth, did not catch up to their littermates, and at time of death, had 
fewer fat stores and muscle tissue.  
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The small size and body wasting observed in the double mutant mice suggested 
that the double mutant mice may have difficulty absorbing nutrients. One study crossed 
a LIG4-/- mouse into a p53-hypomorphic (R172P) background [29]. p53R172P is defective 
in apoptosis but not cell cycle arrest. The p53R172P background rescues the embryonic 
lethality of LIG4 deficiency but these mice were shown to have a diabetic phenotype. I 
asked whether our double mutant mice may also have glucose intolerance. Glucose 
tolerance is thought to decline with age and so mice of three different ages were tested 
(6-7 week, 24 week, and 40 week old mice). Age-matched wildtype and Artemis-P70 
littermates were used as controls. These mice were weighed, fasted for 6 hours, and 
then administered glucose at 0.7g per kg of mouse body weight. Blood glucose levels 
were then measured over the course of two hours (Figure 3.5).  
While there was variability to the timing of the blood glucose peak and baseline 
glucose levels, all mice tested recovered from glucose administration within two hours. 
Additionally, no mouse tested had abnormally high baseline blood glucose. These 
results indicate that Artemis-P70 ATM-/- double mutant mice are glucose tolerant and 
do not have a diabetic phenotype.  
Artemis-P70 ATM-/- double mutant mice have thickened and inflamed colons 
The small size and body wasting phenotype of the double mutant mice 
suggested that although the mice were rescued from lymphoma, the loss of the Artemis 
C-terminus and the ATM kinase have detrimental effects that impact the lifespan of the 
mouse. To investigate the cause of failure to thrive and early death, I examined the 
gastrointestinal tract of the mouse at time of death. Surprisingly, 8 of 8 moribund 
Artemis-P70 ATM-/- mice had abnormal and thickened colons. No age-matched 
littermate controls (0 of 4, genotypes Artemis-P70 ATM+/+ and Artemis-P70 ATM+/-) 
exhibited this phenotype nor did any wildtype mice (Figure 3.6).  
Colon tissues were fixed and sectioned for histology. H&E staining showed that 
unlike the colons of the wildtype and littermate control mice which have organized 
crypts that open on the lumen side, crypts from the double mutant colons had unusual 
branching and were disorganized. Double mutant colons also showed striking 
hyperproliferation that was not present in any control mice (Figure 3.7). I did not 
observe any gross colon phenotypes in Artemis-/- ATM-/- moribund mice (preliminary 
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data, n=4). However, hyperproliferation was observed in two of four colon sections from 
moribund mice stained with H&E (ages 48.4 and 56.4 weeks). The lack of gross 
hyperproliferation suggests that the colon abnormalities in these mice are much milder 
than in Artemis-P70 ATM-/- mice. 
To address the possibility of inflammation in the colon, anti-CD3 
immunohistochemistry was performed on sectioned samples to visualize T-cells. 
Artemis-P70 ATM-/- double mutant colons had increased levels of infiltrating CD3 
positive T cells when compared to wildtype and littermate controls. Taken together, 
these results demonstrate that Artemis-P70 ATM-/- mice colitis, inflammation and 
hyperproliferation of the colon epithelia. (Figure 3.8)  
Pre-moribund mice were also analyzed in order to shed light on the development 
of colitis in Artemis-P70 ATM-/- mice. I analyzed 10 pre-moribund double mutant mice 
between the ages of 5.3 and 29.9 weeks, Of these mice, 7 displayed colon 
hyperproliferation and increased CD3 positive infiltrating T cells (Figure 3.10 A). In 
contrast, of 8 Artemis-P70 littermates between the ages of 5.3 and 55.7 weeks, none 
exhibited this phenotype. Additionally, colitis was not observed in any of the 6 ATM-/- 
mice ages 7 to 26.9 weeks.  
Knowing that the Artemis C-terminus and ATM both are important for the repair 
of DSBs, we hypothesized that the colon inflammation could be brought on by the 
accumulation of DNA damage in the colon, followed by cell death, and a subsequent 
immune response to the dying colon epithelial cells. To address this possibility, colon 
samples with no detectable inflammation were sectioned and stained for 
phosphorylated histone H2AX (the phosphorylated version of the histone is denoted as 
γ-H2AX). In response to DNA damage, H2AX is phosphorylated by ATM and DNA-PKcs 
and is widely used as a marker for DSBs [30]. Both kinases function redundantly in this 
event and so in our case, the loss of ATM would not abrogate H2AX phosphorylation. 
We analyzed three Artemis-P70 ATM-/- mice without signs of colitis (8.6, 13, and 29.1 
weeks of age) and did not detect increased frequency of γ-H2AX positive cells in the 
colon tissue when compared to wildtype mice (Figure 3.9).  
To better understand the nature of the inflammation we had observed in the 
Artemis-P70 ATM-/- mice, lymphoid and myeloid cells were harvested from pre-
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moribund mice colon lamina propria and these cells were analyzed by flow cytometry. 
Despite T cell infiltration and hyperplasia observed using immunohistochemistry, B cell 
infiltration was not observed in the double mutant mice (Figure 3.10 B). Surprisingly, 
there were fewer B cells in double mutant mice than in wildtype, Artemis-P70, and ATM-
/- mice (Artemis-P70 ATM-/- compared to all genotypes p<0.05, Student’s unpaired t-
test). The B cell frequencies appeared to reflect the mature B cell frequencies observed 
in the spleens and did not correlate with the inflammatory phenotype (Table 3.1, IgM+ 
splenocytes).Cells harvested from colon tissue were also analyzed by flow cytometry for 
the presence of the neutrophils. All four Artemis-P70 ATM-/- pre-moribund mice 
analyzed had elevated levels of infiltrating neutrophils when compared to wildtype, 
Artemis-P70, and ATM-/- mice (Figure 3.10 B). These findings confirmed that the innate 
and adaptive immune system both contribute to the inflammatory phenotype.  
Several mouse models for colitis have been shown to be dependent on gut 
bacteria and when these mice are raised in germ free animal facilities, do not develop 
colitis [31-34]. We asked whether our mice harbored bacteria that have been reported to 
be associated with colon inflammation. Fecal pellets from our colony were tested for 
Helicobacter bilis, H. ganmani, H. hepaticus, H. mastomyrinus, H. rodentium, and H. 
typhlonius. We found that our mice were positive for H. hepaticus, and H. ganmani, both 
strains that have been reported to be associated with colitis in mice [35-37]. This finding 
suggests that the immunodeficiency caused by the loss of the Artemis C-terminus and 
ATM resulted in a susceptibility to colonization by Helicobacter. It has been 
demonstrated that the presence of some lymphocyte populations are important for the 
development of severe colitis in response to H. hepaticus [35, 36]. Those findings may 
explain why the double mutant mice, which have low numbers of mature B and T cells 
(Table 3.1), may be especially susceptible to this type of inflammatory response. 
Discussion 
In this study, we characterized the in vivo consequences of the loss of the ATM 
kinase in Artemis-P70 mice. Previously, we have shown that the loss of the Artemis C-
terminus results in both B and T cell deficiencies [11]. There has been evidence 
reported that the loss of cell cycle checkpoint regulators ATM or p53 can rescue 
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embryonic lethality in Lig4-/- and Xrcc4-/- mice [38-40]. NHEJ null mice with lymphocyte 
deficiencies have been crossed into p53-/- backgrounds resulting in minor increases in 
progenitor lymphocytes [38, 41, 42]. These findings raise the possibility that loss of ATM 
could rescue lymphocytes destined for apoptosis and increase the number of 
lymphocytes seen in Artemis-P70 mice. Another possibility was ATM and the Artemis C-
terminus may operate in the same pathway during V(D)J recombination and double 
mutant mice will have similar levels of lymphocytes as single mutants. Supporting this 
hypothesis, past studies have shown that ATM can phosphorylate Artemis at its C-
terminus and these events were dependent on DNA damage [14-16]. We found that 
loss of ATM further decreased both B and T lymphocyte counts. One explanation for 
this finding is that the loss of the Artemis C-terminus and the ATM kinase had a 
negative impact on HSCs which resulted in fewer lymphocyte progenitors. We found 
that there were fewer pro-B cells in Artemis-P70 ATM-/- when compared to the single 
mutants. The pro-B stage is when V(D)J recombination is first initiated but by analyzing 
cells at this stage, it is unclear whether aberrant recombination is resulting in low cell 
counts or whether there are simply fewer progenitors entering this stage. To address 
this issue, we analyzed the HSC population of Artemis-P70 ATM-/- mice but did not 
observe any deficiencies.  
Another explanation for the low lymphocyte counts in double mutant mice is that 
the loss of both the Artemis C-terminus and ATM resulted in levels of aberrant joining 
that were that were so excessive that the vast majority of pro-B cells are programmed to 
undergo apoptosis. We detected increased levels of aberrant transrearrangements in 
Artemis-P70 ATM-/- thymocytes when compared to wildtype but levels were not higher 
than Artemis-P70 or ATM-/- single mutant thymocytes. Thymocytes that have 
undergone nonproductive rearrangements are eliminated from the lymphocyte 
population by apoptosis. Aberrant rearrangements that are in frame and encode a 
receptor, such as receptors that are the result of a transrearrangements, would also be 
selected against if they are unable to recognize the self-MHC molecule. It is possible 
then, that the double mutant thymocytes have levels of aberrant joins that are far above 
Artemis-P70 and ATM-/- thymocytes but were not detected in thymocytes dissected 
directly from mice because they had already been eliminated from the population.  
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I used the Artemis-/- pre-B cell system described in the previous chapter to 
address this issue. This system uses pre-B cells that have a chromosomally integrated 
inversional recombination substrate pMX-INV and can be induced to undergo V(D)J 
recombination upon treatment with the drug STI571 [20]. These cells do not undergo 
apoptosis after induction of V(D)J recombination despite harboring aberrant 
rearrangements [20]. I transduced this line with retrovirus expressing either wildtype 
Artemis, Artemis-ML-CASP, or the Artemis-P70 protein. I found that treatment with 
both STI571 and ATM kinase inhibitor (KU-55933) further increased 
transrearrangements in mutant Artemis-expressing lines beyond levels observed when 
treated with only STI571. This result suggests that loss of ATM in Artemis-P70 
lymphocytes increases levels of aberrant events and this may lead to the severely 
reduced lymphocyte counts observed in double mutant mice. While this does not rule 
out the possibility that ATM may regulate Artemis through phosphorylation of its C-
terminus, it does suggest that ATM may have multiple roles in the prevention of 
aberrant rearrangements. Others have speculated that ATM may also phosphorylate 
the members of the Mre11-Rad50-Nbs1 (MRN) complex, a protein complex that acts in 
DNA DSB repair and has also been shown to be important for preventing aberrant 
rearrangements during V(D)J recombination [43].  
Our lab has previously reported that Artemis-P70 mice bred into a background 
deficient in the cell cycle regulator p53 all succumb to T or B cell lymphoma [17]. 
Because ATM has been shown to act upstream and is important for the activation of 
p53 during DNA damage response [44, 45], we hypothesized that loss of ATM in 
Artemis-P70 mice would result in tumorigenesis. In addition its role in cell cycle 
regulation, ATM also functions in DNA repair and the prevention of transrearrangements 
and so we considered the possibility that mice may succumb to tumors even earlier than 
Artemis-P70 p53-/- mice [18]. We were surprised to find that we did not observe any 
lymphoid tumors in any of the Artemis-P70 ATM-/- mice. One possible explanation for 
the lack of tumors is that lymphocytes of this background exhibit levels of genomic 
instability so high that they cannot support disregulated growth rate. This concept is 
supported by the finding described above in which inhibition of the ATM kinase 
increased aberrant transrearrangements in Artemis-P70 protein expressing pre-B cells. 
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Earlier reports have also shown that Lig4-/- ATM-/- mouse embryonic fibroblasts (MEFs) 
and lymphocytes exhibit increased genomic instability when compared to single mutants 
and Lig4-/- p53-/- demonstrating the additional role of ATM in providing genomic 
stability [39]. Together, these results suggest that Artemis-P70 ATM-/- lymphocytes are 
highly defective in V(D)J recombination and as a consequence, we observed very low 
levels of developing lymphocytes and no tumors. 
Despite being tumor-free, Artemis-P70 ATM-/- mice surprisingly exhibited colon 
inflammation with hyperproliferation of the colon epithelia, elongated and distorted 
crypts, and infiltrating T cells and neutrophils. Currently, the mechanism for the 
development of colitis is unclear. A preliminary test showed that fecal pellets from our 
colony tested positive for Helicobacter ganmani and H. hepaticus, two strains of 
bacteria that have been associated with colitis [37]. H. hepaticus and H. ganmani have 
both been shown to induce colitis in IL-10-/- mice, a well studied model for colitis [37]. 
H. hepaticus has also been used to induce colitis in Rag2 deficient mice lacking B and T 
cells [35]. However, in this model, inflammation seems to require the reconstitution with 
CD4+ T cells from a donor mouse along with H. hepaticus infection. This requirement 
for donor CD4+ T cells seems to be strain dependent as the Rag2 mutation in a 
129SvEv background do not require lymphocytes for H. hepaticus-induced colitis and 
demonstrate that innate immunity can be sufficient in some cases [46, 47]. 
Nevertheless, the experiments with CD4+ T cell reconstitution in Rag2-/- mice illustrate 
that in some cases, the presence of T lymphocytes can exacerbate colon inflammation. 
It is possible that the low levels of B and T cells present in Artemis-P70 ATM-/- mice, 
unable to respond properly to infection, instead cause chronic inflammation. 
A second contributing factor may be the DNA repair defects resulting from 
Artemis and ATM mutations. One report using a dextran sulfate sodium-treatment 
(DSS) colitis mouse model found that ATM-/- mice had a more severe immune 
response to DSS when compared to wildtype mice [48]. The authors speculated that 
reactive oxygen species created by the inflammatory response were more damaging to 
the ATM-/- mouse and the increased DNA damage elicited further inflammation. 
Because our mice have two mutations affecting DNA repair, it is possible that a similar 
mechanism is contributing to the susceptibility to colitis.  
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Yet another possible contributing factor may be an imbalance of immune 
signaling cytokines resulting from loss of ATM. Inhibition of ATM has been shown to 
increase the production of the cytokine IL-23 from dendritic cells, cells that present 
antigen to T-cells [49]. Interestingly, IL-23 mediates inflammatory responses and has 
been shown to be important for the development of colitis in mice [50].     
Together these findings demonstrate that the Artemis C-terminus and ATM 
cooperate to facilitate V(D)J recombination and lymphocyte development. While ATM 
and the Artemis C-terminus may function in the same pathway in some aspects of DSB 
break repair, our in vivo results illustrate that loss of ATM has a negative impact on 
lymphocyte development in Artemis-P70 mice. Loss of both factors also resulted in a 
lack of tumorigenesis but unexpectedly, these mice were susceptible to colitis. This 
indicated that the Artemis C-terminus and ATM both contribute to the development of a 
lymphocyte population that may have important roles in the regulation of intestinal 
homeostasis.  
Materials and methods 
Mice 
Wildtype, Artemis-P70, Artemis-P70 p53-/- Artemis-/-, Artemis-/- p53-/-,ATM-/-, and 
Artemis-P70 ATM-/- mice were all housed in the same specific pathogen free facility. All 
mice were on a mixed 129SvEv and C57BL/6 background.  
Lymphocyte analysis 
Lymphoid organs (bone marrow, thymus, spleen, and lymph nodes) were dissected 
from mice 6-8 weeks old and single cell suspensions were prepared. T cells were 
stained with antibodies for CD4, CD8, and TCRβ. B cells were stained with antibodies 
for B220, IgM, and CD43. Stained cells were analyzed using a BD Accuri C6 flow 
cytometer.  
Hematopoietic stem cell analysis 
The identification of hematopoietic stem cells has been described previously [28]. Bone 
marrow was harvested from mice between the ages of 5 and 24 weeks. Single cell 
suspensions were prepared and the following antibodies were used to exclude lineage 
positive cells: GR1, CD11c, NK1.1, B220, Ter119, CD19, CD11b, CD8, CD3, and 
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TCRβ. Bone marrow cells were also stained with antibodies to identify hematopoietic 
stem cells, CD48, CD150, c-Kit, and Sca1. Stained cells were analyzed using a BD 
FACSCanto flow cytometer. 
PCR Southern blot analysis 
The PCR analysis of TCR rearrangements used in study have been described 
previously [17]. Briefly, genomic DNA was extracted from thymocytes from indicated 
genotypes. Nested PCR was performed using two rounds of the  following program: 30 
cycles of 95 C for 15 seconds, 55 C for 15 seconds, and 72 C for 30 seconds. PCR 
products were purified using Qiagen PCR Purification Kit in between the first and 
second round of PCR. PCR products were run on an agarose gel and transferred to 
Zetaprobe membrane for Southern blotting analysis. To measure band intensity, 
Southern blots were exposed to a phosphorimager screen and scanned on GE 
Healthcare Typhoon Scanner. Typhoon software was used to analyze Southern blot 
images. 
Glucose tolerance test 
Mice were first weighed, transferred to new cages, and then fasted for 6 hours with 
water present. Glucose was administered to these mice by intraperitoneal injection at 
0.7g/kg of mouse weight. Tail blood was analyzed for blood glucose levels over the 
course of 2 hours using a handheld blood glucose monitor. 
Tissue histology 
Tissues were fixed in 10% formalin overnight and transferred to 70% ethanol. Histology 
was performed by the University of Michigan Comprehensive Cancer Center Histology 
and Immunohistochemistry Service. 
Hematopoietic-derived cells isolation from colon tissue 
Isolation of hematopoietic-derived cells from the lamina propria of colon tissue was 
performed following a published protocol [51]. Briefly, colons were isolated and washed. 
Tissues are then minced and digested with collagenase D. Cells released are passed 
through a 70 um strainer. Hematopoietic-derived cells are further isolated using 
Lymphoprep Gradient Medium (Stem Cell Technologies). Cells are then stained and 
analyzed with a FACSCanto flow cytometer. 
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Figure 3. 1 Increased survival of Artemis-P70 ATM-/- double mutant mice. Artemis-P70 
ATM-/-, Artemis-P70 p53-/-l, Artemis-/- p53-/-, and ATM-/- mice were observed for 66 weeks. 
Shown is the Kaplan-Meier survival curve representing the life expectancy for mutant mice. 
Survival curves were compared using two-tailed log-rank test (Artemis-P70 ATM-/- vs. ATM-/-, 
P=0.02; Artemis-P70 ATM-/- vs. Artemis-P70 p53-/-, P<0.001, Artemis-P70 ATM-/- vs. Artemis-
/- p53-/-, P<0.001) 
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Figure 3. 2 Lymphocyte development in Artemis-P70 ATM-/- mice. Lymphocytes from 
thymus, lymph nodes, spleen, and bone marrow were removed from wildtype, Artemis-P70, 
Artemis-P70 ATM-/-, and Artemis-/- mice between the ages of 6 and 8 weeks. Cells were 
stained antibodies for B and T cell surface markers and then analyzed using flow cytometry. 
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Genotype Thymocytes 
CD4+CD8+ 
Thymocytes 
CD4+LN  
T cells 
CD8+ LN  
T cells 
Splenocytes Pro-B cells Pro-B cells Pre-B cells Pre-B cells 
IgM+ 
splenocytes 
 x106 % % % x106 % x106 % x106 % 
Wildtype 
(n=6) 
 
184 ± 49 
 
70 ± 4.7 35 ± 6.9 17 ± 3.6 43 ± 16 1.6 ± 0.21 0.41 ± 0.18 11 ± 3.2 2.6 ± 1.1 29 ± 4.1 
Art-P70
 
(n=6) 
2.6 ± 0.93 66 ± 6.3 15 ± 6.7 12 ± 4.1 5.1 ± 1.4 2.7 ± 0.93 0.38 ± 0.24 1.2 ± 0.43 0.16 ± 0.09 9.8 ± 2.9 
Art-P70 
ATM-/- 
(n=5) 
1.9 ± 0.94 0.49 ± 0.59 2.3 ± 0.90 2.2 ± 1.1 5.7 ± 2.3 0.91 ± 0.40 0.10 ± 0.05 0.14 ± 0.090 0.015 ± 0.010 1.3 ± 1.0 
ATM-/- 
(n=5) 
41 ± 23 54 ± 19 23 ± 3.6 18 ± 3.2 19 ± 9.1 2.6 ± 0.38 0.37 ± 0.1 6.4 ± 2.7 0.92 ± 0.47 25 ± 2.9 
Art-/- 
(n=5) 
0.11 ± 0.05 0.04 ± 0.0 0.46 ± 0.49 0.03 ± 0.03 7.1 ± 2.9 1.9 ± 1.5 0.40 ± 0.18 0.22 ± 0.13 0.05 ± 0.02 0 ± 0 
 
Table 3. 1 Lymphocyte counts and percentages of Artemis-P70 ATM-/- mice. Wildtype, 
Artemis-P70, Artemis-P70 ATM-/-, and Artemis-/- lymphocytes from thymus, lymph nodes, 
spleen, and bone marrow were harvested from mice between the ages of 6 and 8 weeks. Table 
represents cell frequencies determined by cell counts and flow cytometric analysis using 5-6 
mice per genotype. 
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Figure 3. 3 Artemis-P70 ATM-/- mice do not exhibit a HSC deficiency. Bone marrow was 
collected from wildtype (n = 2) and Artemis-P70 ATM-/- (n = 4) mice between the ages of 5 and 
24 weeks. Flow cytometric analysis was performed to measure the frequency of lineage-, c-kit+, 
Sca1+, CD48-, and CD150+ HSCs. No significant differences in HSC frequency was found in 
Artemis-P70 ATM-/- mice when compared to wildtype mice.   
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Figure 3. 4 Aberrant transrearrangements in Artemis-P70 ATM-/- thymocytes. A, B) 
Genomic DNA was isolated from wildtype, Artemis-P70, ATM-/-, and Artemis-P70 ATM-/- 
thymocytes. Intrachromosomal rearrangements within the TCR locus (D2-J2, chr. 6) were 
amplified using nested PCR and visualized using Southern blot. Interchromosomal aberrant 
transrearrangements between TCRD2 and TCRV (chr. 6 and chr. 13, respectively) were also 
amplified using nested PCR. Amplification of the Rag2 gene was used as normalization. C) 
PCR Southern blot from Figure 3.3B was exposed to a phosphorimager screen and band 
intensity was calculated using phosphorimager software. The graph represents the ratio of 
aberrant to normal joins based on band intensity. 
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Figure 3. 5 Glucose tolerance in Artemis-P70 ATM-/- mice. Wildtype, Artemis-P70, and 
Artemis-P70 ATM-/- mice of various ages (6-7 weeks, 24 week, and 40 weeks) were fasted for 6 
hours. Mice were then injected with a glucose solution at 0.7g of glucose per kg of mouse body 
weight. Blood glucose levels during recovery were then measured over the course of 120 
minutes. 
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Figure 3. 6 Abnormally thickened colons of Artemis-P70 ATM-/- mice. Gastrointestinal 
tracts from A) wildtype, B) littermate controls, and C-F) Artemis-P70 ATM-/- double mutant mice 
were removed from moribund mice. Shown is the general morphology of the colon from these 
mice. 
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Figure 3. 7 H & E colon histology Colons from A) wildtype, B) littermate controls, and C-D) 
moribund Artemis-P70 ATM-/- double mutant mice were fixed, sectioned, and stained with H&E. 
Shown are representative images of the distal colon at 100x, 200x, and 400x magnification.  
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Figure 3. 8 CD3 colon histology Colons from A) wildtype, B) littermate controls, and C-D) 
Artemis-P70 ATM-/- double mutant mice were fixed and sectioned. Immunohistochemistry was 
performed to visualize CD3 positive T cells in the colon. Shown are representative images from 
the distal colon at 100x, 200x, and 400x magnification. 
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Figure 3. 9 γ-H2AX colon histology Colons from wildtype, Artemis-P70 ATM-/-, and Artemis-
P70 ATM+/- or Artemis-P70 ATM+/+ littermates were harvested. Immunohistochemistry was 
performed to visualize phosphorylated histone H2AX in uninflamed colon tissue. All images 
shown were taken at 400x magnification. 
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Figure 3. 10 Colon inflammation was observed in mice as early as 5.3 weeks. A) Colons 
were harvested from non-moribund Artemis-P70 ATM-/- mice and their Artemis-P70 ATM+/- and 
Artemis-P70 ATM+/+ littermates. Colons were also collected from wildtype and ATM-/- mice 
between 7 and 27 weeks of age. Tissue sections were stained with H & E and 
immunohistochemistry was performed to visualize CD3+ T cells. All images shown were taken 
at 200x magnification. B) Lymphoid and myeloid cells from the colon lamina propria were 
harvested and analyzed by flow cytometry. Graphs representing the percent frequency of B 
cells and neutrophils found in the lamina propria. (B cells: wildtype n=4, Artemis-P70 n= 5, 
Artemis-P70 ATM-/- n=8, ATM-/- n=4) (Neutrophils: wildtype n=2, Artemis-P70 n=2, Artemis-
P70 ATM-/- n=4, ATM-/- n=4) 
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Chapter 4 
Summary of findings and discussion 
 
Mechanisms of post-cleavage complex stability 
The Artemis C-terminus phosphorylation and protein interaction 
In this body of work, I have demonstrated in vitro that the loss of the Artemis C-
terminus results in increased aberrant inversional rearrangements and this phenotype 
was made worse when combined with a deficiency in the cell cycle and DNA repair 
kinase ataxia-telangiectasia mutated (ATM). The impact of the loss of both factors was 
additive in vivo as well and these mice had a lymphocyte deficiency that was more 
severe than mice with loss of only one factor. Unexpectedly, this deficiency resulted in a 
tumor-free mouse with a susceptibility to colitis. I hypothesize the phenotypes observed 
in the mice can be attributed to the severely defective V(D)J recombination caused by 
the loss of the Artemis C-terminus and the ATM kinase.  
Our results as well as others have suggested that both the Artemis C-terminus 
and ATM participate in the stabilization of a protein complex important for synapsis of 
cleaved DNA ends, a complex we and others have referred to as the post-cleavage 
complex (PCC).  The precise mechanism regarding how the Artemis C-terminus and the 
ATM kinase are facilitating proper recombination through PCC stabilization has not yet 
been elucidated. In discussing their precise roles, we first should consider the 
components of the PCC and factors and events that have been shown to be important 
for the synapsis of DNA ends. 
 The Rag endonuclease was the first and most established component 
determined to be important for the synapsis of the DNA ends created by Rag-cleavage. 
Using in vitro assays, it was found that after DNA cleavage, all DNA ends, two signal 
and two coding ends, were retained in a RAG1/RAG2 synaptic complex [1, 2]. 
Furthermore, Rag mutations were shown to disrupt this complex despite leaving the 
Rag cleavage activity unaffected [3, 4]. Using a PCC disrupting point mutant, our lab 
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generated a RAG1 S723C mutant mouse. Thymocytes from these mice exhibited 
increased inter-chromosomal transrearrangements and when crossed into a p53-/- 
background, double-mutant mice succumbed to thymic lymphoma. These tumors 
harbored clonal rearrangements that were distinct from p53-/- thymic lymphomas [5]. 
Together, these findings illustrate that after Rag cleavage, coding and signal ends are 
held together in synaptic complex involving the Rag proteins and disrupting this 
complex result in the loss of these ends, aberrant rearrangements, and in a p53-/- 
background, tumorigenesis.  
A factor that has been shown to be important for DNA synapsis during double-
stranded break (DSB) repair is the DNA-dependent protein kinase catalytic subunit 
(DNA-PKcs). It is possible that synapsis through DNA-PKcs is one aspect of post-
cleavage complex stability. This kinase along with the NHEJ DNA-end sensor proteins 
KU70 and KU80 (when together, referred to as DNA-PK) were shown to synapse DNA 
ends and synapsis was shown to increase the kinase activity of DNA-PKcs [6, 7]. The 
exact function of DNA-PKcs kinase activity and autophosphorylation is complex and has 
not yet been completely elucidated. Early studies have found that autophosphorylation 
inactivated the kinase activity of DNA-PKcs and also disrupted its interaction with 
KU70/80 and DNA [8]. However, the exact phosphorylation sites that are responsible for 
inactivation and protein-DNA complex dissociation have not been identified. 
Phosphorylation of DNA-PKcs seems to have other functions unrelated to 
complex disruption. DNA-PKcs bound to ends in an in vivo phosphorylation-inhibited 
environment seems to protect the DNA ends from nucleases. However, when 
autophosphorylation is permitted, DNA-PKcs is thought to undergo a conformational 
change that allows nucleases to act on DNA ends [7]. Supporting the this finding, two 
clusters of phosphorylation sites referred to as ABCDE and PQR have been 
characterized and these clusters were found to be important for restricting and 
permitting nuclease access to DNA ends[9]. More recently, it was found that a DNA-
PKcs phosphorylation event was necessary for Artemis recruitment and this event could 
be carried out by either DNA-PKcs or the ATM kinase. However, this study also showed 
that there was another phosphorylation event that strictly required DNA-PKcs activity 
and this was important for ligation [10]. 
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Based on these findings, the phosphorylation events of DNA-PKcs are 
hypothesized to occur in the following sequence. KU70/80 first recognizes and binds to 
DNA ends. This is followed by the recruitment of DNA-PKcs which protects the ends 
from nuclease digestion. DNA ends are then synapsed and phosphorylation is activated 
which recruits Artemis. The ABCDE cluster is phosphorylated, allowing Artemis and 
perhaps other nucleases access to DNA ends. The PQR cluster is then phosphorylated, 
restricting further nuclease activity. DNA-PKcs autophosphorylation occurs at a yet 
undefined location which promotes ligation and then dissociation.  
One possibility is that the Artemis C-terminus plays a structural role in stabilizing 
the PCC with phosphorylation of this domain by DNA-PKcs and/or ATM facilitating this 
function. This domain may aid in stabilizing the protein complex at DNA ends, perhaps 
supporting several weak interactions between different factors. Supporting this 
hypothesis, I found that loss of the DNA-PKcs interaction domain of the Artemis C-
terminus resulted in increased aberrant V(D)J rearrangement products when compared 
to experiments done with truncation mutants containing this domain.  
There are several lines of evidence that suggest phosphorylation of this domain 
may also play a role. Both DNA-PKcs and ATM have been shown to phosphorylate 
Artemis at its C-terminus and ATM phosphorylation seems to be the primary kinase 
during recovery from ionizing radiation [11-16]. We and others have shown that the loss 
of ATM or inhibition of its kinase activity can result in increased aberrant V(D)J 
rearrangements and coding end accumulation [17]. This observation was strikingly 
similar to our results showing increased aberrant rearrangements and coding end 
accumulation in Artemis-P70 lymphocytes. When I treated pre-B cells expressing 
Artemis C-terminal truncated protein with an ATM kinase inhibitor drug, I observed an 
increase in transrearrangements that exceeded the loss of the Artemis C-terminus 
alone. This finding would suggest that ATM may also phosphorylate other factors 
important for PCC stability. 
Another report found that the DSB repair protein complex MRE11-RAD50-NBS1 
(MRN) seemed to function in PCC stability [18]. They found that hypomorphic mutations 
of Mre11 and Nbs1 resulted in increased aberrant V(D)J rearrangements and coding 
end accumulation. Because all three members of the MRN complex are phosphorylated 
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by ATM [19], the authors speculated that ATM may phosphorylate MRN and this 
regulates a DNA-synapsing activity of the protein complex. Interestingly, when 
Mre11/Nbs1-hypomorphic cell lines were treated ATM kinase inhibitor, they found that 
aberrant products were further increased. Although the involvement of other factors 
cannot be ruled out, one enticing possibility is that ATM may phosphorylate both the 
MRN complex and the Artemis C-terminus and these phosphorylation events may 
stabilize the PCC. (Figure 4.1) 
Prevention of DNA-PKcs dissociation 
One of the early findings regarding DNA-PKcs autophosphorylation was that this 
event can result in inactivation and dissociation of DNA-PKcs from DNA ends and Ku 
proteins. [8]. This dissociation has not yet been linked to PCC instability and this 
possible relationship may be difficult to explore. For instance, it is currently unknown 
which phosphorylation sites are important for DNA-PKcs dissociation and in addition, it 
has been shown that DNA-PKcs kinase activity is required for Artemis-mediated DNA 
hairpin opening [10, 20]. One possible way in which the Artemis C-terminus prevents 
loss of DNA ends from the PCC is that it may inhibit premature DNA-PKcs dissociation-
associated phosphorylation. Perhaps after Artemis cleaves the DNA hairpin, DNA-PKcs 
phosphorylates the Artemis C-terminus. In this model, this phosphorylation event may 
not necessarily serve a function. However, without the Artemis C-terminus available as 
a substrate, DNA-PKcs may phosphorylate itself at sites associated with inactivation 
and dissociation. The PCC may then become destabilized before DNA-PKcs can 
facilitate ligation (Figure 4.2). Supporting this hypothesis, it has been shown in the past 
that incubating DNA-PKcs with a synthetic phosphorylation peptide substrate prevented 
the self-inactivation of the kinase [8].  
Reduced endonucleolytic activity of Artemis-P70 may destabilize the PCC 
The work presented in this work as well as previous findings from our lab have 
suggested the Artemis C-terminus is important for stabilizing the PCC. However, it has 
been difficult to separate the nuclease function of the Artemis nuclease and its putative 
PCC-stabilizing function. We have shown in this body of work and in past studies that 
the Artemis C-terminus is important for endonucleolytic activity [21]. The two truncation 
mutants MβL/βCASP and D451X (Artemis-P70) which I and others in our lab have 
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demonstrated to facilitate aberrant V(D)J rearrangements both have reduced levels of 
nuclease activity. One possible way in which reduced nuclease activity could result in 
destabilized PCC is at DNA ends, a partially functional nuclease may only open DNA 
hairpins a portion of the time. In this scenario, there may be a population of complexes 
in which only one of the two hairpin coding ends will be opened. Unable to join these 
two ends, the PCC may eventually collapse resulting in an open hairpin coding that can 
be joined to a signal end or a Rag-generated DNA end from another locus. (Figure 4.3) 
The cause of colitis in Artemis-P70 ATM-/- mice 
How the loss of ATM may contribute to colon inflammation 
Despite not observing any tumors in our Artemis-P70 ATM-/- mice, surprisingly, 
all moribund mice exhibited thickened colons with infiltrating T cells and neutrophils. 
These results suggest that Artemis-P70 ATM-/- mice may be uniquely susceptible to 
this type of inflammation when compared to their littermates. Here we discuss the 
potential contributing factors that may be leading to this phenotype in our double mutant 
mice.  
A possible contributing factor to colitis is the impaired DNA repair in the double 
mutant mice. Although our preliminary data examining γ-H2AX-positive cells did not 
seem to show increased DNA damage in our double-mutant mice, it is possible that the 
immunohistochemistry done was not able to detect the accumulation of DSB in non-
apoptotic cells. Most positive cells were found at the distal end of the intestinal crypt 
suggesting that the γ-H2AX-positive cells were apoptotic cells that have undergone 
DNA fragmentation.  
Support for this hypothesis comes from a report using a mouse model for colitis 
that is induced by oral administration of a sulfated polysaccharide, dextran sodium 
sulfate (DSS) [22]. Adding DSS to the drinking water of mice induces colitis exhibiting 
hyperproliferation [23] as well as neutrophils and lymphocyte infiltration [24]. DSS, 
thought to be toxic to the colon epithelia, damages the barrier between the lumen and 
mucosa and antigens from the lumen illicit an inflammatory response. Westbrook et al. 
found that ATM-/- mice treated with DSS exhibited a higher disease activity index, a 
scoring system they used based on weight loss and stool consistency. Colon tissue 
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from these mice had higher levels of DNA damage that the authors speculated were a 
consequence of the inflammatory response.  
The authors of that study hypothesized that colon tissue deficient in ATM may 
not be able to repair the DNA damage induced by the inflammatory response. Cellular 
stress and DNA damage has been shown to stimulate the immune system by increasing 
the presence of the cell-surface ligand NKG2D which is in turn recognized by natural 
killer (NK) cells of the innate immune system [25]. This would result in a positive 
feedback loop wherein an inflammatory response releases reactive oxygen species, 
surrounding ATM deficient cells are unable to repair the DNA damage, and this induces 
further inflammatory response. It is possible that this mechanism is a factor in the 
development of colitis in our Artemis-P70 ATM-/- mice.   
Another possible contributing factor to colitis is that the loss of ATM may increase 
the production of an immune signaling molecule, the cytokine IL-23 [26]. Wang et al. 
found that dendritic cells, a type of cell that presents antigens to T cells, increased 
production of IL-23 when ATM was inhibited by the drug KU-55933. IL-23 is known to 
promote the survival and expansion of Th17 cells, a subset of T cells that produce an 
inflammatory cytokine IL-17. Interestingly, IL-17 levels have been shown to be 
increased in colon tissues from patients suffering from ulcerative colitis and Crohn’s 
disease [27]. Others have found that for one model of murine colitis IL-10-/-, a combined 
deficiency in IL-23 resulted in disease-free mice suggesting that IL-23 may play a critical 
role in the development of colon inflammation. [28].  
Autoimmunity as a contributing factor 
Our lab has in the past generated the Rag1 S723C mouse and these mice 
exhibited “leaky” severe combined immunodeficiency (SCID) with severely reduced 
levels of B and T cells [5]. Another group analyzed these mice and found that these 
mice produced self-reactive autoantibodies [29]. The authors of this paper likened this 
phenotype to Omenn syndrome, a SCID resulting from hypomorphic Rag endonuclease 
mutations. Human patients with Omenn syndrome exhibit very low levels of B and T 
cells, inflammatory skin disease (erythroderma), hair loss, and colitis. Although only 4% 
of these mice exhibited colitis and hair loss, the authors found that some mutant mice 
had B and T cell infiltration in the small and large intestine, stomach, kidney, liver, and 
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lung  [29]. In addition, these mice were found to produce autoantibodies. Walter et al. 
speculated that there were two contributing factors resulting in the development of 
autoantibodies: impaired receptor editing and B-cell activating factor (BAFF)-mediated 
survival.  
Developing B cells in the bone marrow which have undergone V(D)J 
recombination may bind to self-antigens. These B cells will then re-express Rag genes 
and restart V(D)J recombination to rearrange the light chain. The authors found that 
receptor editing, like V(D)J recombination, was also impaired in Rag1 S723C mice. 
Walter et al. also found that BAFF, a B-cell survival cytokine was elevated in Rag 
mutant humans, Artemis mutant humans, and Rag1 S723C mice. This cytokine is 
thought to be expressed in B-cell lymphopenic environments in order to promote the 
survival of B-cells. The authors speculate that the high levels of BAFF can rescue self-
reactive B cells that were programmed for apoptosis. [29] 
We did not analyze our Artemis-P70 ATM-/- mice for self-antibodies and it is 
unclear whether the mechanisms that played a role in the Rag1 S723C mice also 
contributed to the colitis observed in our mice. The Walter et al. found that human 
Artemis patients also had high levels of serum BAFF and because of the very low levels 
of mature B cells in our mice, it is likely that we would also observe high levels of this 
cytokine. We also did not examine our Artemis-P70 ATM-/- mice for defective receptor 
editing but a positive result would be unsurprising given the defects in V(D)J 
recombination. Therefore, it is plausible that our mice may be producing autoantibodies 
and this may contribute to the colitis. However, unlike in the Rag1 S723C mice, we did 
not observe B cell infiltration in the colons nor did we observe lymphocyte infiltration in 
the kidney and liver. It would also be expected that if autoantibodies were being 
generated in the double mutant mice in this manner, that we would observe 
inflammation in other organs. Yet, we observed a very specific and very penetrant 
phenotype of colon inflammation. And so although the mechanism described by Walter 
et al, may be contributing, there are likely other factors that are also at play.  
Helicobacter-induced colitis 
It is been reported that certain immunodeficient mice are susceptible to colitis 
and these mice do not exhibit this phenotype when raised in germfree conditions [30-
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33]. Additionally, the majority of mouse models for inflammatory bowel disease depend 
on gut bacteria suggesting the bacteria itself plays an important role in the development 
of colitis [34]. To address whether our mice harbored pathogenic bacteria in the gut, we 
had histology slides stained and fecal pellets analyzed for the presence of Helicobacter 
species. Helicobacter species are commonly found in mouse colonies and have been 
shown to cause colitis in some immunodeficient mice. One study found that mouse 
colonies in 6 of 16 U.S. academic institutions tested positive for H. hepaticus [35] and 
another study from Germany found that 35 of 40 mouse strains housed in specific 
pathogen free animal facilities tested positive for Helicobacter bacteria [36]. Although 
slides stained and analyzed by a pathologist were not found to be Helicobacter positive, 
fecal pellets analyzed by PCR indicated that Helicobacter ganmani and Helicobacter 
hepaticus DNA were present, two strains of bacteria that have been associated with 
colitis [37].  
In our animal facility, we house Artemis-/- and Rag2-/- mice along with the 
Artemis-P70 ATM-/- mice. Although the Artemis-/- and Rag2-/- mice have not yet been 
tested for Helicobacter, it is possible that these strains are also infected. However, we 
have not observed diarrhea or body wasting in these mice housed in the same room 
and as mentioned above, we never observed colitis in the Artemis-P70 ATM+/- and 
Artemis-P70 ATM+/+ littermates. These observations suggest that the Artemis-P70 
ATM-/- mice may be particularly susceptible to colon inflammation in response to 
Helicobacter. One possible explanation for this sensitivity may lie in the severely 
reduced, but present B and T cell population in Artemis-P70 ATM-/- mice. Double 
mutant mice may not have enough lymphocytes to mount a proper immune response to 
clear the infection but the presence of lymphocytes may be driving a chronic 
inflammatory response that results in hyperproliferation we observed. Supporting this 
hypothesis, past studies have found that not all immunodeficient mice exhibit colon 
inflammation even when administered H. hepaticus. Rag2-/- mice, which lack B and T 
cells, have been used as a model to study H. hepaticus-induced colitis [38]. However, 
using this model required the reconstitution of CD4+ T cells along with Helicobacter 
administration, suggesting that in some cases, the presence of lymphocytes is required 
for inflammation.  
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Helicobacter species, as well as some other gram negative pathogenic bacteria, 
employ the bacterial toxin cytolethal distending toxin (CDT) [39]. This toxin has been 
shown to cause cell cycle arrest and cell death in host cells. CDT consists of three 
subunits, CdtA, CdtB, and CdtC. The importance of this toxin in virulence was shown 
using H. hepaticus strains in which CDT expression was disrupted [40]. Young et al., 
using the IL-10 mouse colitis model, infected mice with CDT-mutant H. hepaticus, and 
found that these mice exhibited only mild colitis when compared to mice infected with 
wildtype H. hepaticus. Notably, CdtB was found to have DNase-I-like activity which was 
abolished with a point mutation to a putative active site [41]. 
The DNase-I-like activity of CdtB has been shown to activate the ATM 
phosphorylation cascade in a similar manner as ionizing radiation [42]. Furthermore, 
ATM-deficient fibroblasts were shown to be more sensitive to Haemophilis ducreyi CDT 
(57% sequence similarity to H. hepaticus CdtB [43]). Because our mice are deficient in 
both ATM and Artemis, it is very possible that if they are H. hepaticus positive, that their 
DNA repair deficiencies may play a role in their development of colitis.  
Although we have not fully characterized the mechanism driving colon inflammation 
in our double mutant mice, I hypothesize that several factors at play make these mice 
more susceptible. Our preliminary data on the presence of Helicobacter DNA in fecal 
pellets suggest that these pathogenic bacteria may be cause of colitis but further 
experiments will be necessary to establish that Helicobacter is a contributing factor. As 
a control, our Rag2-/- and Artemis-/- mice should also be tested for infection. Prior 
research has shown that it is possible these mice could harbor Helicobacter species but 
do not display any signs of body wasting or colitis. Chronic inflammation in the double 
mutant mice may be partially driven by low levels of B and T cells. Additionally, loss of 
DNA repair factors may be promoting a positive feedback loop in which reactive oxygen 
species produced by the inflammatory response to gut bacteria damage the DNA of the 
colon epithelia, the DNA is inefficiently repaired, and this drives further inflammation. 
Lastly, loss of ATM may be increasing the levels of proinflammatory cytokines that 
further promotes colitis.  
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Future directions 
A few experiments can be performed to address the underlying mechanism for 
the loss of PCC stability in Artemis-P70 lymphocytes. In the first model proposed at the 
beginning of the chapter (Figure 4.1), the PCC is dependent on the phosphorylation of 
the Artemis C-terminus as well as its interaction with DNA-PKcs. An Artemis mutant 
construct containing alanine substitutions at the 8 C-terminus SQ phosphorylation sites 
as well as mutations at L401 R402, the DNA-PKcs interaction site, can be generated. 
This mutant can then be expressed in the pre-B cell system with the chromosomally 
integrated inversional recombination substrate. No study has yet tested a 
phosphorylation-deficient mutant Artemis construct in inversional recombination and this 
experiment may reveal the importance of these sites in PCC stability.  
In my second model, the Artemis C-terminus serves as a phosphorylation 
substrate to prevent autophosphorylation leading to inactivation/dissociation of DNA-
PKcs (Figure 4.2). One way in which this hypothesis can be tested is to test the kinase 
activity of DNA-PKcs in the presence of the Artemis C-terminus peptide. DNA-PKcs, in 
the presence of linear DNA will lose kinase activity over time but the presence of the C-
terminus peptide may prevent loss of activity. Dissociation of DNA-PKcs has also been 
tested in vitro with DNA-PKcs-DNA complex formation analyzed by electron microscopy 
[44]. A similar assay can be performed in the presence of the C-terminus peptide to test 
its ability to prevent DNA-PKcs dissociation. 
I also hypothesized that the reduced endonucleolytic activity may result in a 
destabilized PCC if only one of two coding ends are opened within one complex (Figure 
4.3). To test this hypothesis, a full length Artemis protein with a hypomorphic mutation 
affecting nuclease activity can be expressed in the pre-B cell system I described 
chapter 2. Expressing a full-length Artemis protein with reduced nuclease activity could 
potentially separate the functions of the nuclease domain with the potential functions of 
the C-terminal domain. In this study, we analyzed an Artemis T71A mutant that was 
based on a human disease Artemis T71P mutation. Although we found that the Artemis 
T71A mutation did not alter endonucleolytic activity, it is possible that a proline 
substitution would be more likely to affect activity. Patients with this mutant allele were 
lymphopenic with some T cells present [45]. The presence of some lymphocytes in 
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these patients suggests that this allele is hypomorphic and may be useful in addressing 
reduced nuclease activity in PCC stability. The full length Artemis-T71P mutant protein, 
if found to exhibit nuclease activity comparable to Artemis-P70 or MβL/βCASP, can be 
expressed in the pre-B cell system described in Chapter 2 and assayed for its 
propensity for facilitating aberrant V(D)J recombination.  
Lastly, it will be important to determine the cause of colitis in the Artemis-P70 
ATM-/- mice. Preliminary results suggest that our mice are Helicobacter positive. If 
further experiments indicate that they are indeed positive, this line will have to be 
rederived to generate a Helicobacter-free colony. These mice can then be administered 
Helicobacter bacteria to address its contribution. Other genotypes can also be 
administered Helicobacter to test whether the double mutant mice are uniquely 
susceptible to colitis.   
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Figure 4. 1 Phosphorylation of the Artemis C-terminus and PCC stability. The stabilization 
of the PCC by the Artemis C-terminus may depend on its interaction with DNA-PKcs and 
phosphorylation by DNA-PKcs and ATM. Loss of the C-terminus, like in Artemis-P70 and 
MβL/βCASP expressing cells, may result in loss of PCC stability due to loss of phosphorylation 
sites and in the case of MβL/βCASP, the additional loss of the DNA-PKcs interaction domain.  
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Figure 4. 2 Artemis C-terminus may prevent DNA-PKcs inactivation/dissociation In normal 
wildtype cells, DNA-PKcs phosphorylates the Artemis C-terminus after binding to DNA ends. 
When the Artemis C-terminus is not present, DNA-PKcs loses its phosphorylation substrate and 
instead, phosphorylates itself in a way that results in inactivation and dissociation from the DNA 
ends.  
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Figure 4. 3 Reduced activity of Artemis mutants may destabilize the PCC Loss of the 
Artemis C-terminus results in reduced endonucleolytic activity. Only one of two coding ends 
within the PCC is opened by mutant Artemis because of its reduced endonucleolytic activity. 
Unable to join the two ends, the PCC then collapses.  
 
